0001078782-13-002187.txt : 20131112 0001078782-13-002187.hdr.sgml : 20131111 20131112151947 ACCESSION NUMBER: 0001078782-13-002187 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131112 DATE AS OF CHANGE: 20131112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOETHICS LTD CENTRAL INDEX KEY: 0000894560 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 870485312 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 033-55254-41 FILM NUMBER: 131209885 BUSINESS ADDRESS: STREET 1: 1137 NORTH 120 WEST CITY: AMERICAN FORK STATE: UT ZIP: 84003 BUSINESS PHONE: 505-681-4210 MAIL ADDRESS: STREET 1: 1137 NORTH 120 WEST CITY: AMERICAN FORK STATE: UT ZIP: 84003 10-Q 1 f10q093013_10q.htm FORM 10-Q QUARTERLY REPORT SEPTEMBER 30 2013 FORM 10-Q Quarterly Report September 30 2013

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


Form 10-Q


(Mark One)


  X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2013


      . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ______________________________ to ______________________________


Commission File Number 33-55254-41


BIOETHICS, LTD.

(Exact name of registrant as specified in charter)

 

 

NEVADA

87-0485312

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

182 S. 400 E., Alpine, Utah

84004

(Address of principal executive offices)

(Zip Code)

 

 

(505) 681-4210

(Issuer’s telephone number, including area code)

 

 

_______________________________________________________

(Former name, former address, and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days  Yes  X . No      .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  X . No      .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer

      .

Accelerated filer

      .

Non-accelerated filer

      . (Do not check if a smaller reporting company)

Smaller reporting company

  X .


Indicate by check mark whether the issuer is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes  X . No      .


As of November 12, 2013, the issuer had outstanding 11,000,000 shares of common stock, par value $0.001.




1



BIOETHICS, LTD.


FORM 10-Q


FOR THE QUARTER ENDED SEPTEMBER 30, 2013



INDEX


PART I   Financial Information

 

 

 

 

Item 1.  Financial Statements (Unaudited)

 

 

 

 

 

Unaudited Condensed Balance Sheets

3

 

Unaudited Condensed Statements of Operations

4

 

Unaudited Condensed Statements of Cash Flows

5

 

Notes to Unaudited Condensed Financial Statements

6

 

 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

8

 

 

 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

10

 

 

 

Item 4.  Controls and Procedures

10

 

 

 

PART II Other Information

 

 

 

 

Item 1.  Legal Proceedings

11

 

 

 

Item 1A.  Risk Factors

11

 

 

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

11

 

 

 

Item 3.  Defaults Upon Senior Securities

11

 

 

 

Item 4.  Mine Safety Disclosures

11

 

 

 

Item 5.  Other Information

11

 

 

 

Item 6.  Exhibits

11

 

 

 

SIGNATURES

12




2



PART I – FINANCIAL INFORMATION


Item 1. Financial Statements.


BIOETHICS, LTD.

[A Development Stage Company]

UNAUDITED CONDENSED BALANCE SHEETS

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

2013

 

2012

CURRENT ASSETS

 

 

 

 

   Cash

$

529

$

4,505

 

 

 

 

 

             Total Current Assets

 

529

 

4,505

 

 

 

 

 

 

$

529

$

4,505

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

   Accounts payable

$

-

$

-

   Accrued Interest Payable - Stockholder

 

10,667

 

7,291

   Notes Payable – Stockholder

 

80,000

 

70,000

 

 

 

 

 

             Total Current Liabilities

 

90,667

 

77,291

 

 

 

 

 

        Total Liabilities

 

90,667

 

77,291

 

 

 

 

 

STOCKHOLDERS’ EQUITY (DEFICIT):

 

 

 

 

   Common stock; $.001 par value,

       25,000,000 shares authorized,

       11,000,000 shares issued and

       outstanding

 

11,000

 

11,000

 

 

 

 

 

 

 

 

 

 

 

 

   Capital in excess of par value

 

92,776

 

92,776

   Deficit accumulated during the

       development stage

 

 

 

 

 

(193,914)

 

(176,562)

 

 

 

 

 

             Total Stockholders’ Equity (Deficit)

 

(90,138)

 

(72,786)

 

 

 

 

 

 

$

529

$

4,505

 

 

 

 

 

Note: The balance sheet at December 31, 2012 was taken from the audited financial statements at that date and condensed.

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.




3




BIOETHICS, LTD.

[A Development Stage Company]

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three

 

For the Nine

 

From Inception

 

 

 

Months Ended

 

Months Ended

 

On July 26, 1990

 

 

 

September 30,

 

September 30,

 

Through Sept 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

REVENUE

 

$

-

$

-

$

-

$

-

$

-

 

 

 

 

 

 

 

 

 

 

 

 

EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

   General and administrative

 

 

4,548

 

6,852

 

13,976

 

17,020

 

183,247

 

 

 

 

 

 

 

 

 

 

 

 

LOSS BEFORE OTHER

  INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,548)

 

(6,852)

 

(13,976)

 

(17,020)

 

(183,247)

 

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

   Interest Expense

 

 

(1,210)

 

(1,006)

 

(3,376)

 

(2,502)

 

(10,667)

 

 

 

 

 

 

 

 

 

 

 

 

LOSS BEFORE INCOME TAXES

 

 

(5,758)

 

(7,858)

 

(17,352)

 

(19,522)

 

(193,914)

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT TAX EXPENSE

 

 

-

 

-

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

DEFERRED TAX EXPENSE

 

 

-

 

-

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

$

(5,758)

$

(7,858)

$

(17,352)

$

(19,522)

$

(193,914)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS PER COMMON SHARE

 

$

0.00

$

0.00

$

0.00

$

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements




4




BIOETHICS, LTD.

[A Development Stage Company]

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

 

 

 

 

 

 

 

 

 

 

 

 

 

From Inception

 

 

 

 

 

 

on July 26,

 

 

For the Nine Months Ended

 

1990 Through

 

 

September 30,

 

September 30,

 

 

2013

 

2012

 

2013

Cash Flows from Operating Activities:

 

 

 

 

 

 

   Net loss

$

(17,352)

$

(19,522)

$

(193,914)

   Adjustments to reconcile net loss to net cash

 

 

 

 

 

 

         Changes in assets and liabilities:

 

 

 

 

 

 

           Increase (decrease) in accounts payable

 

-

 

997

 

-

           Increase (decrease) in accrued interest         

 

3,376

 

2,502

 

10,667

 

 

 

 

 

 

 

            Net Cash (Used) by Operating Activities

 

(13,976)

 

(16,023)

 

(183,247)

 

 

 

 

 

 

 

Cash flows from Investing Activities:

 

-

 

-

 

-

 

 

 

 

 

 

 

            Net Cash Provided by Investing Activities

 

-

 

-

 

-

 

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

   Proceeds from common stock issuance

 

-

 

-

 

41,000

   Capital contribution

 

-

 

-

 

62,776

   Proceeds from notes payable

 

10,000

 

20,000

 

80,000

 

 

 

 

 

 

 

            Net Cash Provided by Financing Activities

 

10,000

 

20,000

 

183,776

 

 

 

 

 

 

 

Net Increase (Decrease) in Cash

 

(3,976)

 

3,977

 

529

 

 

 

 

 

 

 

Cash at Beginning of Period

 

4,505

 

6,989

 

-

 

 

 

 

 

 

 

Cash at End of Period

 

529

 

10,966

 

529

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosures of Cash Flow Information:

 

 

 

 

 

 

     Cash paid during the period for:

 

 

 

 

 

 

       Interest

$

-

$

-

$

-

       Income Taxes

$

-

$

-

$

-

 

 

 

 

 

 

 

  Supplemental schedule of Non-cash Investing and Financing Activities:

 

 

 

 

 

 

       For the nine months ended September 30, 2013:

 

 

 

 

 

 

              None

 

 

 

 

 

 

 

 

 

 

 

 

 

       For the nine months ended September 30, 2012:

 

 

 

 

 

 

              None

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.




5




BIOETHICS, LTD.

[A Development Stage Company]


NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS


NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Organization - Bioethics, Ltd. (“the Company”) was organized under the laws of the State of Nevada on July 26, 1990. The Company has not commenced planned principal operations and is considered a development stage company as defined in ASC Topic No. 915. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of, and at the complete discretion of, the Company’s officers and directors.  The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.


Condensed Financial Statements - The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2013 and 2012 and for the periods then ended have been made.


Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2012 audited financial statements.  The results of operations for the periods ended September 30, 2013 and 2012 are not necessarily indicative of the operating results for the full year.


NOTE 2 - CAPITAL STOCK


Common Stock - In July 1990, in connection with its organization, the Company issued 1,000,000 shares of its previously authorized but unissued common stock.  Total proceeds from the sale of stock amounted to $1,000 (or $.001 per share).


In May 1998, the Company issued 10,000,000 shares of its previously authorized but unissued common stock.  Total proceeds from the sale of stock amounted to $40,000 (or $.004 per share).  The issuance of common stock resulted in a change in control of the Company.


Capital Contribution - During the years 2005 to 2009, the Company received a total of $62,776 in shareholder contributions.


NOTE 3 - RELATED PARTY TRANSACTIONS


Management Compensation - During the nine months ended September 30, 2013 and 2012, the Company did not pay any compensation to its officers and directors.


Office Space - The Company has not had a need to rent office space.  An officer/shareholder of the Company is allowing the Company to use his home as a mailing address, as needed, at no expense to the Company.


Notes Payable - In January 2010, the Company borrowed $25,000 from a stockholder of the Company pursuant to an unsecured promissory note.  In May and June 2011, the Company borrowed $5,000 and $20,000 from a stockholder of the Company pursuant to unsecured promissory notes.  In July 2012, the Company borrowed $20,000 from a stockholder of the Company pursuant to an unsecured promissory note.  In May 2013, the Company borrowed $10,000 from a stockholder of the Company pursuant to an unsecured promissory note.  Such notes are due on demand and accrue interest at 6% per annum.  At September 30, 2013 accrued interest on such notes was $10,667.




6



BIOETHICS, LTD.

[A Development Stage Company]


NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS


NOTE 4 - GOING CONCERN


The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.  However, the Company has incurred losses since its inception and has no on-going operations.  These factors raise substantial doubt about the ability of the Company to continue as a going concern.  In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans, additional sales of its common stock or through a possible business combination.  There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations.  The financial statements do not include any adjustments that might result from the outcome of these uncertainties.


NOTE 5 - LOSS PER SHARE


The following data show the amounts used in computing loss per share:


 

For the Three

Months Ended
September 30,

For the Nine

Months Ended
September 30,

 

    2013

    2012

2013

2012

 

 

 

 

 

Loss from continuing operations

 

 

 

 

applicable to common

 

 

 

 

stockholders (numerator)

$      (5,758)

$      (7,858)

$      (17,352)

$      (19,522)

 

 

 

 

 

Weighted average number of

 

 

 

 

common shares outstanding

 

 

 

 

used in loss per share calculation

 

 

 

 

during the period (denominator)

11,000,000

11,000,000

11,000,000

11,000,000


Dilutive loss per share was not presented, as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share.


NOTE 6 – SUBSEQUENT EVENTS


The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are no additional events to disclose.



7




Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.


You should read the following discussion in conjunction with our financial statements, which are included elsewhere in this report.  The following information contains forward-looking statements. (See “Forward-Looking Statements” and “Risk Factors.”)


FORWARD-LOOKING STATEMENTS


This report contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995.  These statements reflect the Company’s views with respect to future events based upon information available to it at this time.  These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from these statements.  These uncertainties and other factors include, but are not limited to the risk factors described herein under the caption “Risk Factors.”  The words “anticipates,” “believes,” “estimates,” “expects,” “plans,” “projects,” “targets” and similar expressions identify forward-looking statements.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, changes in assumptions, future events or otherwise.


General


The Company is a shell company that conducts no active business operations and is seeking business opportunities for acquisition or participation by the Company.


The Report of Independent Registered Public Accounting Firm on the Company’s 2012 audited financial statements addresses an uncertainty about the Company’s ability to continue as a going concern, indicating that the Company has incurred losses since its inception and has no on-going operations.  The report further indicates that these factors raise substantial doubt about the Company’s ability to continue as a going concern.  At September 30, 2013, the Company had a working capital deficit of $90,138 and a stockholders’ deficit of $90,138.  The Company incurred net losses of $5,758 for the three months ended September 30, 2013 and $17,352 for the nine months ended September 30, 2013.  The Company has not entered into any agreements or arrangements for the provision of additional debt or equity financing and there can be no assurance that it will be able to obtain the additional debt or equity capital required to continue its operations.  


The Three and Nine Month Periods ended September 30, 2013 Compared to the Three and Nine Month Periods ended September 30, 2012


The Company did not conduct any operations during its fiscal quarters ended September 30, 2013 or 2012, respectively, and had no assets other than cash.  At September 30, 2013, the Company had cash in the amount of $529 as compared to cash at December 31, 2012 in the amount of $4,505.  The decrease in cash is the result of the receipt of a $10,000 stockholder loan in May, 2013 offset in part by the payment of expenses.  At September 30, 2013, the Company had total current liabilities of $90,667, consisting of accrued interest payable - stockholder of $10,667 and notes payable – stockholder of $80,000, as compared to total current liabilities of $77,291 at December 31, 2012 consisting of accrued interest payable – stockholder of $7,291 and notes payable - stockholder of $70,000.  The Company had a working capital deficit of $90,138 at September 30, 2013 as compared to a working capital deficit of $72,786 at December 31, 2012.   


The Company did not generate revenues during the first nine months of 2013 or 2012.  The Company incurred general and administrative expenses of $4,548 during the three months ended September 30, 2013 as compared to $6,852 during the three months ended September 30, 2012.  The Company incurred general and administrative expenses of $13,976 during the nine months ended September 30, 2013 as compared to $17,020 during the nine months ended September 30, 2012.  Such expenses consist primarily of legal and accounting fees as well as taxes and annual fees required to maintain the Company’s corporate status.    


The Company incurred a net loss of $5,758 during the three months ended September 30, 2013 as compared to a net loss of $7,858 during the three months ended September 30, 2012 with the difference being attributable to a decrease in general and administrative expenses during 2013 that was partially offset by an increase in interest expense.  The Company incurred a net loss of $17,352 during the nine months ended September 30, 2013 as compared to a net loss of $19,522 during the nine months ended September 30, 2012 with the difference being attributable to a decrease in general and administrative expenses during 2013 that was partially offset by an increase in interest expense.  



8




Net cash used by operating activities was $13,976 for the nine months ended September 30, 2013 resulting from the net loss of $17,352 and a $3,376 increase in accrued interest.  Net cash used by operating activities was $16,023 during the nine months ended September 30, 2012 resulting from the net loss of $19,522 partially offset by a $997 increase in accounts payable and a $2,502 increase in accrued interest.   


No cash was provided or used by investing activities during the first nine months of 2013 or 2012.


Net cash provided by financing activities during the nine months ended September 30, 2013 was $10,000 as a result of a demand loan from a stockholder.  Net cash provided by financing activities during the nine months ended September 30, 2012 was $20,000 as a result of a demand loan from a stockholder.  All of such stockholder loans bear interest at 6% per annum.  


Since the Company does not generate any revenues from operations, it is dependent on sales of securities, loans, or contributions from its stockholders in order to pay its operating costs.  During May and June 2011 the Company borrowed $25,000 from a stockholder pursuant to unsecured promissory notes.  During July 2012, the Company borrowed $20,000 from a stockholder pursuant to an unsecured promissory note.  During May, 2013, the Company borrowed $10,000 from a stockholder pursuant to an unsecured promissory note.  Such notes are due on demand and bear interest at the rate of 6% per annum.  As of September 30, 2013, the Company had expended all but $529 of the proceeds from the May, 2013 loan, its current liabilities exceeded its current assets by $90,138 and the Company requires additional contributions to capital, loans, or proceeds from sales of its common stock in order to continue its operations.  In addition, in the event the Company locates a suitable candidate for potential acquisition, the Company will require additional funds to pay the costs of negotiating and completing the acquisition of such candidate.  The Company has not entered into any agreement or arrangement for the provision of any additional funding and no assurances can be given that such funding will be available to the Company on terms acceptable to it or at all.  


The Company cannot presently foresee the cash requirements of any business opportunity which may ultimately be acquired by the Company.  However, since it is likely that any business it acquires will be involved in active business operations, the Company anticipates that an acquisition will result in increased cash requirements as well as increases in the number of employees of the Company.


Off-Balance Sheet Arrangements


The Company has not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.


Critical Accounting Policies


Due to the lack of current operations and limited business activities, the Company does not have any accounting policies that it believes are critical to facilitate an investor’s understanding of the Company’s financial and operating status.


Recent Accounting Pronouncements


The Company has not adopted any new accounting policies that would have a material impact on the Company’s financial condition, changes in financial condition or results of operations.


Item 3.  Quantitative and Qualitative Disclosures About Market Risk.


Not Applicable.  The Company is a “smaller reporting company.”




9




Item 4.  Controls and Procedures.


Disclosure Controls and Procedures


Under the supervision and with the participation of our management, including our Chief Executive Officer/Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (“the Exchange Act”) as of September 30, 2013, the end of the period covered by this report.  Based upon that evaluation, our Chief Executive Officer/Chief Financial Officer, who is our sole officer and director, concluded that our disclosure controls and procedures as of September 30, 2013 were effective such that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer/Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure.  A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.  


Changes in Internal Control over Financial Reporting


There was no change in our internal control over financial reporting during the quarter ended September 30, 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


In connection with an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2012, using the COSO framework, our management, with the participation of our Chief Executive Officer/Chief Financial Officer identified a weakness in the Company’s internal control, which arises from the fact that the Company’s principal executive and principal financial officers are the same person, which does not allow for segregation of duties.  Our management believes the materiality of this weakness is mitigated by the Company’s status as a shell company with no significant assets or liabilities, no business operations and a limited number of transactions each year, and that the weakness does not have a material effect on the accuracy and completeness of our financial reporting and disclosure as included in this report.




10




Part II—OTHER INFORMATION


Item 1.  Legal Proceedings.


The Company is not a party to any material pending legal proceedings and, to the best of its knowledge, its properties are not the subject of any such proceedings.


Item 1A.  Risk Factors.


See the risk factors described in Item 1A of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2012.


Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.


Not Applicable.


Item 3.  Defaults Upon Senior Securities.


Not Applicable.


Item 4.  Mine Safety Disclosures.


Not Applicable.


Item 5.  Other Information.


Not Applicable.


Item 6.  Exhibits


The following documents are included as exhibits to this report:


(a) Exhibits


Exhibit

Number

 

SEC

Reference

Number

 

Title of Document

 

Location

 

 

 

 

 

 

 

3.1

 

3

 

Articles of  Incorporation

 

Incorporated by

Reference*

3.2

 

3

 

Bylaws

 

Incorporated by

Reference*

31.1

 

31

 

Section 302 Certification of Chief Executive and

  Chief Financial Officer

 

This Filing

32.1

 

32

 

Section 1350 Certification of Chief Executive and

  Chief Financial Officer

 

This Filing

101.INS**

 

 

 

XBRL Instance Document

 

This Filing

101.SCH**

 

 

 

XBRL Taxonomy Extension Schema

 

This Filing

101.CAL**

 

 

 

XBRL Taxonomy Extension Calculation Linkbase

 

This Filing

101.DEF**

 

 

 

XBRL Taxonomy Extension Definition Linkbase

 

This Filing

101.LAB**

 

 

 

XBRL Taxonomy Extension Label Linkbase

 

This Filing

101.PRE**

 

 

 

XBRL Taxonomy Extension Presentation Linkbase

 

This Filing


*Incorporated by reference to Exhibits 3(i) and 3(ii) of the Company’s 2003 Form 10-KSB report, filed March 30, 2004.


**XBRL information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other document.




11




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



 

Bioethics, Ltd.

 

 

 

 

Date:  November 12, 2013

By  /s/ Jed Beck   

 

Jed Beck

 

President, Chief Executive Officer and

 

Chief Financial Officer

 

(Principal Executive and Financial Officer)




12


EX-31.1 2 f10q093013_ex31z1.htm EXHIBIT 31.1 SECTION 302 CERTIFICATION Exhibit 31.1 Section 302 Certification

Exhibit 31.1


I, Jed Beck, certify that:


1.

I have reviewed this report on Form 10-Q of Bioethics, Ltd;


2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:


a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: November 12, 2013

/s/ Jed Beck   

Jed Beck

President, Chief Executive Officer and

Chief Financial Officer

(Principal Executive Officer and

Principal Financial Officer)



EX-32.1 3 f10q093013_ex32z1.htm EXHIBIT 32.1 SECTION 906 CERTIFICATION Exhibit 32.1 Section 906 Certification

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Bioethics, Ltd. (the “Company”) on Form 10-Q for the fiscal quarter ended September 30, 2013 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Jed Beck, President, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



November 12, 2013

/s/ Jed Beck  

Jed Beck

President, Chief Executive Officer and

Chief Financial Officer




EX-101.INS 4 both-20130930.xml XBRL INSTANCE DOCUMENT 529 4505 529 4505 529 4505 0 0 10667 7291 80000 70000 90667 77291 90667 77291 11000 11000 92776 92776 -193914 -176562 -90138 -72786 529 4505 0.001 0.001 25000000 25000000 11000000 11000000 11000000 11000000 0 0 0 0 0 4548 6852 13976 17020 183247 -4548 -6852 -13976 -17020 -183247 -1210 -1006 -3376 -2502 -10667 -5758 -7858 -17352 -19522 -193914 0 0 0 0 0 0 0 0 -5758 -7858 -17352 -19522 -193914 0.00 0.00 0.00 0.00 -17352 -19522 -193914 0 997 0 3376 2502 10667 -13976 -16023 -183247 0 0 0 0 0 41000 0 0 62776 10000 20000 80000 10000 20000 183776 -3976 3977 529 4505 6989 0 529 10966 529 0 0 0 0 0 0 0 0 0 <!--egx--><p style='margin:0cm 0cm 0pt'><b><font lang="EN-US">NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></b></p> <p style='margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Organization -</font></b><font lang="EN-US"> Bioethics, Ltd. (&#147;the Company&#148;) was organized under the laws of the State of Nevada on July 26, 1990. The Company has not commenced planned principal operations and is considered a development stage company as defined in ASC Topic No. 915. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of, and at the complete discretion of, the Company&#146;s officers and directors.&nbsp; The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Condensed Financial Statements - </font></b><font lang="EN-US">The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2013 and 2012 and for the periods then ended have been made.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><font lang="EN-US">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.&nbsp; It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company&#146;s December 31, 2012 audited financial statements.&nbsp; The results of operations for the periods ended September 30, 2013 and 2012 are not necessarily indicative of the operating results for the full year.</font></p> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt'><b><font lang="EN-US">NOTE 2 - CAPITAL STOCK</font></b></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Common Stock</font></b><font lang="EN-US"> - In July 1990, in connection with its organization, the Company issued 1,000,000 shares of its previously authorized but unissued common stock.&nbsp; Total proceeds from the sale of stock amounted to $1,000 (or $.001 per share).</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p><font lang="EN-US">In May 1998, the Company issued 10,000,000 shares of its previously authorized but unissued common stock.&nbsp; Total proceeds from the sale of stock amounted to $40,000 (or $.004 per share).&nbsp; The issuance of common </font> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt'><b><font lang="EN-US">NOTE 3 - RELATED PARTY TRANSACTIONS</font></b></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Management Compensation -</font></b><font lang="EN-US"> During the nine months ended September 30, 2013 and 2012, the Company did not pay any compensation to its officers and directors.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Office Space</font></b><font lang="EN-US"> <b>-</b> The Company has not had a need to rent office space.&nbsp; An officer/shareholder of the Company is allowing the Company to use his home as a mailing address, as needed, at no expense to the Company.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Notes Payable</font></b><font lang="EN-US"> - In January 2010, the Company borrowed $25,000 from a stockholder of the Company pursuant to an unsecured promissory note.&nbsp; In May and June 2011, the Company borrowed $5,000 and $20,000 from a stockholder of the Company pursuant to unsecured promissory notes.&nbsp; In July 2012, the Company borrowed $20,000 from a stockholder of the Company pursuant to an unsecured promissory note.&nbsp; In May 2013, the Company borrowed $10,000 from a stockholder of the Company pursuant to an unsecured promissory note.&nbsp; Such notes are due on demand and accrue interest at 6% per annum.&nbsp; At September 30, 2013 accrued interest on such notes was $10,667. </font></p> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt'><b><font lang="EN-US">NOTE 4 - GOING CONCERN</font></b></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='line-height:normal;margin:0cm 0cm 0pt 18pt'><font lang="EN-US">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.&nbsp; However, the Company has incurred losses since its inception and has no on-going operations.&nbsp; These factors raise substantial doubt about the ability of the Company to continue as a going concern.&nbsp; In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans, additional sales of its common stock or through a possible business combination.&nbsp; There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations.&nbsp; The financial statements do not include any adjustments that might result from the outcome of these uncertainties.</font></p> <p style='margin:0cm 0cm 0pt'>&nbsp;</p> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt'><b><font lang="EN-US">NOTE 5 - LOSS PER SHARE</font></b></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><font lang="EN-US">The following data show the amounts used in computing loss per share:</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="598" style='width:448.6pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="192" colspan="2" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:143.75pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">For the Three </font></p> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">Months EndedSeptember 30,</font></p></td> <td valign="top" width="192" colspan="2" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:144.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">For the Nine </font></p> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">Months EndedSeptember 30,</font></p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">&nbsp;&nbsp;&nbsp; 2013</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">&nbsp;&nbsp;&nbsp; 2012</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">2013</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="center" style='text-align:center;margin:0cm 0cm 0pt'><font lang="EN-US">2012</font></p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">Loss from continuing operations</font></p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">applicable to common</font></p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">stockholders (numerator)</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5,758)</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7,858)</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (17,352)</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (19,522)</font></p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">&nbsp;</font></p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">Weighted average number of</font></p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">common shares outstanding</font></p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">used in loss per share calculation</font></p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'>&nbsp;</p></td></tr> <tr style='height:7.2pt'> <td valign="top" width="214" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:160.55pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p style='margin:0cm 0cm 0pt'><font lang="EN-US">during the period (denominator)</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.95pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">11,000,000</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:71.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">11,000,000</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72.3pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">11,000,000</font></p></td> <td valign="top" width="96" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:72pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> <p align="right" style='text-align:right;margin:0cm 0cm 0pt'><font lang="EN-US">11,000,000</font></p></td></tr></table></div> <p style='line-height:normal;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='line-height:normal;margin:0cm 0cm 0pt 18pt'><font lang="EN-US">Dilutive loss per share was not presented, as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share.</font></p> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt'><b><font lang="EN-US">NOTE 6 &#150; SUBSEQUENT EVENTS</font></b></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><font lang="EN-US">The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are no additional events to disclose.</font></p> <p style='margin:0cm 0cm 0pt'>&nbsp;</p> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Organization -</font></b><font lang="EN-US"> Bioethics, Ltd. (&#147;the Company&#148;) was organized under the laws of the State of Nevada on July 26, 1990. The Company has not commenced planned principal operations and is considered a development stage company as defined in ASC Topic No. 915. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of, and at the complete discretion of, the Company&#146;s officers and directors.&nbsp; The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <!--egx--><p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><b><font lang="EN-US">Condensed Financial Statements - </font></b><font lang="EN-US">The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2013 and 2012 and for the periods then ended have been made.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'>&nbsp;</p> <p style='text-align:justify;margin:0cm 0cm 0pt 18pt'><font lang="EN-US">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.&nbsp; It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company&#146;s December 31, 2012 audited financial statements.&nbsp; The results of operations for the periods ended September 30, 2013 and 2012 are not necessarily indicative of the operating results for the full year.</font></p> <p style='text-align:justify;margin:0cm 0cm 0pt'>&nbsp;</p> <!--egx--><p style='margin:0in 0in 0pt 0.25in;text-align:justify'>The following data show the amounts used in computing loss per share:</p> <p style='margin:0in 0in 0pt 0.25in;text-align:justify'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" width="598" border="0" style='width:448.6pt;border-collapse:collapse'> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="192" colspan="2" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:143.75pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="center" style='margin:0in 0in 0pt;text-align:center'>For the Three </p> <p align="center" style='margin:0in 0in 0pt;text-align:center'>Months EndedSeptember 30,</p></td> <td valign="top" width="192" colspan="2" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:144.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="center" style='margin:0in 0in 0pt;text-align:center'>For the Nine </p> <p align="center" style='margin:0in 0in 0pt;text-align:center'>Months EndedSeptember 30,</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="center" style='margin:0in 0in 0pt;text-align:center'>&nbsp;&nbsp;&nbsp; 2013</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="center" style='margin:0in 0in 0pt;text-align:center'>&nbsp;&nbsp;&nbsp; 2012</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="center" style='margin:0in 0in 0pt;text-align:center'>2013</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="center" style='margin:0in 0in 0pt;text-align:center'>2012</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>Loss from continuing operations</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>applicable to common</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>stockholders (numerator)</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5,758)</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7,858)</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (17,352)</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (19,522)</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>Weighted average number of</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>common shares outstanding</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>used in loss per share calculation</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>&nbsp;</p></td></tr> <tr style='height:0.1in'> <td valign="top" width="214" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:160.55pt;padding-top:0in;border-bottom:#ece9d8;height:0.1in;background-color:transparent'> <p style='margin:0in 0in 0pt'>during the period (denominator)</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.95pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>11,000,000</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:71.8pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>11,000,000</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:72.3pt;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>11,000,000</p></td> <td valign="top" width="96" style='border-right:#ece9d8;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0in;border-left:#ece9d8;width:1in;padding-top:0in;border-bottom:windowtext 1pt solid;height:0.1in;background-color:transparent'> <p align="right" style='margin:0in 0in 0pt;text-align:right'>11,000,000</p></td></tr></table></div> <p style='margin:0in 0in 0pt 0.25in;line-height:normal'>&nbsp;</p> 1000000 10000000 1000 40000 0.001 0.004 62776 -5758 -7858 -17352 -19522 11000000 11000000 11000000 11000000 62776 0 25000 5000 20000 20000 10000 0.0600 0.0600 0.0600 0.0600 0.0600 0 0 0 0 0 10667 10-Q 2013-09-30 false BIOETHICS LTD 0000894560 --12-31 11000000 Smaller Reporting Company Yes No No 2013 Q3 0000894560 2013-01-01 2013-09-30 0000894560 2013-11-12 0000894560 2013-09-30 0000894560 2012-12-31 0000894560 2013-07-01 2013-09-30 0000894560 2012-07-01 2012-09-30 0000894560 2012-01-01 2012-09-30 0000894560 1990-07-26 2013-09-30 0000894560 1990-07-01 0000894560 1998-05-01 0000894560 2012-04-01 2012-09-30 0000894560 2005-01-01 2009-12-31 0000894560 2012-07-31 0000894560 2011-06-30 0000894560 2010-01-31 0000894560 2011-05-31 0000894560 2013-05-31 shares iso4217:USD iso4217:USD shares pure EX-101.CAL 5 both-20130930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 both-20130930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 both-20130930_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Accrued Interest On Notes Accrued Interest On Notes RELATED PARTY TRANSACTIONS: Net Cash Provided by Financing Activities Common Stock, Shares Authorized Accounts payable Entity Central Index Key Supplemental schedule of Non-cash Investing and Financing Activities Supplemental schedule of Non-cash Investing and Financing Activities Capital contribution EXPENSES: REVENUE Parentheticals CURRENT TAX EXPENSE Total Liabilities CAPITAL STOCK CONTRIBUTION: SUBSEQUENT EVENTS Increase (decrease) in accounts payable Notes Payable - Stockholder Borrowed From a Stockholder Portion of the carrying amount as of the balance sheet date of obligations evidenced by notes or loan agreements due all related parties that is payable after one year or beyond the normal operating cycle if longer. COMPUTING LOSS PER SHARES: Net Cash (Used) by Operating Activities Changes in assets and liabilities: Net loss LOSS PER COMMON SHARE Entity Filer Category Amendment Flag Going Concern Note Cash paid during the period for: Proceeds from notes payable Increase (decrease) in accrued interest Operating Activities: Capital Stock Transactions Cash Flows from Operating Activities: REVENUE: Common stock; $.001 par value, 25,000,000 shares authorized, 11,000,000 shares issued and outstanding STOCKHOLDERS' EQUITY (DEFICIT): Total Current Assets Document Fiscal Year Focus Per share value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. ACCOUNTING POLICIES Deficit accumulated during the development stage Total Current Liabilities Accrued Interest Payable - Stockholder Entity Well-known Seasoned Issuer Received shareholder contributions RELATED PARTY TRANSACTIONS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Income Taxes Interest Net Increase (Decrease) in Cash Cash Flows from Financing Activities: OTHER INCOME (EXPENSE) Entity Public Float condensed financial statements Organization LOSS PER SHARE {1} LOSS PER SHARE Supplemental Disclosures of Cash Flow Information: Cash at Beginning of Period Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Proceeds from common stock issuance Adjustments to reconcile net loss to net cash used by operating activities: DEFERRED TAX EXPENSE LOSS BEFORE INCOME TAXES Total Liabilities and Stockholders' Equity (Deficit) CURRENT ASSETS RELATED PARTY TRANSACTION: Company issued shares previously authorised but unissed common stock Company issued shares previously authorised but unissed common stock Weighted average number of common shares outstanding used in loss per share calculation during the period (denominator) Loss from continuing operations applicable to common stockholders (numerator) Cash Flows from Investing Activities: NET LOSS Common Stock, Shares Outstanding Total Stockholders' Equity (Deficit) Entity Common Stock, Shares Outstanding Shareholders contributions Capital contributions from the shareholders GOING CONCERN: Net Cash Provided by Investing Activities Document Fiscal Period Focus Accrued Interest Rate Per Annum Accrued Interest Rate Per Annum Amounts Used In Computing Loss Per Share Common Stock, Par Value Entity Voluntary Filers Document Period End Date SUBSEQUENT EVENTS {1} SUBSEQUENT EVENTS CAPITAL STOCK: LOSS BEFORE OTHER INCOME (EXPENSE) Current Fiscal Year End Date Entity Registrant Name Cash at End of Period Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Total Assets Cash {1} Cash Document Type Document and Entity Information Total proceeds from the sale of stock amounted Total proceeds from the sale of stock amounted Amounts Used In Computing Loss Per Share {1} Amounts Used In Computing Loss Per Share LOSS PER SHARE SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Interest Expense Common Stock, Shares Issued CURRENT LIABILITIES ASSETS CAPITAL STOCK General and administrative Capital in excess of par value Entity Current Reporting Status EX-101.PRE 8 both-20130930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 9 both-20130930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000160 - Statement - CAPITAL STOCK CONTRIBUTION (Details) link:presentationLink link:definitionLink link:calculationLink 000140 - Statement - COMPUTING LOSS PER SHARE (Details) link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - UNAUDITED CONDENSED STATEMENTS of CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 000060 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - UNAUDITED CONDENSED BALANCE SHEETS PARENTHETICALS link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - LOSS PER SHARE link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000150 - Statement - Capital Stock Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 000170 - Statement - RELATED PARTY TRANSACTION (Details) link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - CAPITAL STOCK link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - UNAUDITED CONDENSED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - Amounts Used In Computing Loss Per Share (Table) link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink XML 10 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTION (Details) (USD $)
Sep. 30, 2013
May 31, 2013
Jul. 31, 2012
Jun. 30, 2011
May 31, 2011
Jan. 31, 2010
RELATED PARTY TRANSACTION:            
Borrowed From a Stockholder   $ 10,000 $ 20,000 $ 20,000 $ 5,000 $ 25,000
Accrued Interest Rate Per Annum 0.00% 6.00% 6.00% 6.00% 6.00% 6.00%
Accrued Interest On Notes $ 10,667 $ 0 $ 0 $ 0 $ 0 $ 0
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!1PT*[H0$``!@-```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,EUUOPB`4AN^7[#\TW"Z6 MXC;G%JL7^[C<3.9^`"NGEDB!`#K]]Z/XD<5T&C.3<5-2X)SW*4G?O`Q&RUHD M"S"6*YDCDF8H`5DHQN4T1Q^3ETX?)=91R:A0$G*T`HM&P\N+P62EP2:^6MH< M5<[I!XQM44%-;:HT2+]2*E-3YU_-%&M:S.@4<#?+>KA0TH%T'=?T0,/!$Y1T M+ESRO/33:Q(#PJ+D<;VQT2[:ET-@JIKPQ[;,6UO?(8"+%WIVBOP6<+KB7NJ&Y9S!@+=HXW&N&WP```/__`P!02P,$ M%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V? M5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@ M\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8` M"````"$`T45'SVP!``"="P``&@`(`7AL+U]R96QS+W=O.4F[\U6'Y5,]J7&3/[$OL?3@-V_K^VKJJV@!==?/:@W(T6_%N;HVT`'!:5 MI@:7L6G+\O%D/4-BQF_#B'E@&C$G<;S*<1@:7,2,2SX^!0416@EI9!4XGQ5E M1B2!:41"XH26(T@[H>70;M+04:545`F.87]3SS;20/GN#`YUBX7/D^]JFZ(1 M/F&F>7L!F;;.(Y@<-Z&#(G,2P=60;I:!@UJ2MR8TC:!QO'Y2TY4E;G%,VMGX MS,JZ4X<_9I=/>UQ3_1<^V]]A8T'!>'5Q!\R&@A&AU8C)#;_ZJ][R8F]NWJC1^T48RP<>F4JJJT7-L^MRK"N+DC7#>?88C5BN5T)O)-1;G:01I:$@7RY9K5 MTIS09#L:4'#YI-/=VP$F:O1O;( MM"9]D*1T:W\6-0.C;Z#L9:WV#P%O:?S.0=BGNQJ\*V_O"(9.X8`KIMYQ MR'?N,P$M;%T/H3+'-)IK!C=-6#BM<)V215XV"U$PPWX<;Q'4[#^RB\"WTO0MCS_3B+D";&@>^EQW3)T&ORO66(O#E.4>Q_UU== M::LNAILGP1S*GN&EEZ!GC!(O2CT?A7&DN]#&J]_XIRE>!@DTWTL"?9D>`,<>KDNS:1K\R*!/.'@<=,O5F^X<1?"/HZW: M93P/_3``!:)D.8.#YR,YKMYTYRB"7B4V7$F<25K`=X!]4=4;!6<:G@MYP-&[ M[AQET(\7RPRU8@ZMP#.J"-/T.`=ZCE+HDYHI4N)4B?P5HX9P2?+NS&I).N=` MSU$,#_+3MA,EX10$QM&0ZE:JJ]_:9$"=!"SC"[&;WWW>,^;+#&O8E"9[C8Y^9P9[)]MM[GFEO MN*0I*78Z6IBZAHN$G-+BLM-__AL]K72-5G%QBC-2X)W^@:G^;?_[;]L[*5_H M%>-*`X:"[O1K5=TVAD&3*\YCNB`W7(#E3,H\KN"QO!CT5N+X5$_*,\,R3=?( MX[30.<.FG,-!SNGM*2'X# MBF.:I=5'3:IK>;+Y?BE(&1\ST/V.EG'2E'6F#P-L2) M1>!(R`N#?C^Q(9AL/,R.Z@C\76HG?(Y?L^H?%V0!$3MCE]!)@F MX%&@65@.8TI(!AN`3RU/66J`1^+W^ON>GJKK3K?=A>.9-@*X=L2TBE)&J6O) M*ZU(_A\'H8:*DU@-"^F:#LH M;('"%BILT;A-D`@GS'R)#"S%>"7*\#D$%NZ\(,=X$A%,(L))1*1""`Z`,VR^ M`QA8BO%:<@"'N'6,E\Y2\L]A:'97\J$7#,W(7GO2*Q0*=L^TI"R*!/O*MI9] M"@JJX>0=JF:GN`U7I?I,8Y-$]:ZTOL\A7/W3B'S!/J)?L(\Y0`2,>$`$*%S` M"K;!1::6SL!BYKO2S>)SB"KS)Q'!)"*<1$0JA)`#ZZ\X@(&EV/>W1GUX^QS2 MQ!Y92,J-@VB'JE9\4UH\$.S)=]Y/<1Y#H\R-?HR7E4AWB M-YA&NN,Y\ELO`KR5#`A$`/)L^60()<3:L63],L)>H_[L%2*/6-$S._=KM.2! MGIC'OL$L1Z\VE3%0&4.5,>J,8W>-J)>5///U\@)I>).[4B'F(X[Y1*_"&*AF MABICU!FG];(*9[Y>7@\)>J5WTT<9[@!=*@@?ZPZ/)<(X9+]Z@(67'XZ@Q4!E#E9'UN8P6/D>J*9[AO(_E'5J. MRPL^X"RC6D)>68]JP_O8C7;]\[/%VA)IW$<;Z*<>QP.T@:8)QHUN`K2[M_B" M_XK+2UI0+<-G6,I<>%!SE;QAY@\5N=7]XI%4T.C6/Z_PQP:&3LU<`/A,2-4^ ML`6ZOTKV_P,``/__`P!02P,$%``&``@````A``+R']'4`@``1`@``!D```!X M;"]W;W)K&ULE)5=;YLP%(;O)^T_6+XO8`+D0R%5 M4]9MTB9-TSZN'3#!*F!D.TW[[W>,$P2D8DDN,(Y?/S[O.<9>W[]6)7IA4G%1 MQY@X'D:L3D7&ZWV,?_]ZNEM@I#2M,UJ*FL7XC2E\O_GX87T4\ED5C&D$A%K% MN-"Z6;FN2@M64>6(AM4PD@M940U=N7=5(QG-VDE5Z?J>%[D5Y36VA)6\AB'R MG*FA8K6V$,E*JB%^5?!&G6E5>@VNHO+YT-REHFH`L>,EUV\M%*,J77W= MUT+270F^7TE`TS.[[5S@*YY*H42N'<"Y-M!+STMWZ0)IL\XX.#!I1Y+E,7X@ MJR3"[F;=YNT>J$,?/DF??>,T@V5`F4X"=$,]&^C4S?\%D]V+V4UN` M'Q)E+*>'4O\4QR^,[PL-U0[!D/&URMX2IE)(*&`4?N(&B5%Z4%I4?ZV(G%`6XI\@T)X@Q'?\14C" MZ`;*[$2!]DSQ'!)XMS""$P/:,X,X@1_.%U?X<6UNVE0G5-/-6HHC@NT+[E5# MS<=`5D`V.9Y!I=[/,237S'DPD]JIH%:P+UXV))BOW17IVY@.WXC!)D:]\)<=M[6XM1K(2*<)AHK' M_RJ2*<4@>@BE'_UU13"38@QK=!&2T!O&N+6:*1=6$=DB>O8WA"3O2#K%P`:L M<[L-,VEL@W1\6PRKF;)A%8O61F!<#`E)?YSTAP<&X%CH&YC>148\#GRTQ;=6 M,Q6X52QMX([-?_SHU=,^^4[GGM4(ERV&+>\XCJHB>S!6ZCJE<=2C!&JA,UD7*?WY8_TPH<0Z7F>\TC6D]!4L?9I_ M_#`[:+.U)8`C2*AM2DOGFBEC5I2@N(UT`S5^R;51W.'2%,PV!GC6;E(5Z_=Z M8Z:XK&D@3,T]#)WG4L!*BYV"V@6(@8H[S-^6LK%GFA+WX!0WVUWS(+1J$+&1 ME72O+902):;/1:T-WU3H^Q@/N3BSV\4-7DEAM-6YBQ#'0J*WGA_9(T/2?)9) M=.#+3@SD*5W$T^60LOFLK<\O"0=[\4QLJ0^?C+S2C3L,PGRXI3.0RJ??+?([MQ3ZV M+[M/9AE>7`<:OQ]H\#^!O!@[=V4@Z;@A=M`,+S1_RW!E$27W6_3BE**OB])- MWD0.FDE;_'$_2=XZ#L,=>J_`%/`)JLH2H7=^<&/.&FD+4E%>2XM1.!,'F!:SF($";;LE:#)'#WBZ M]9&SF%7^_&;T*,]^6S+EQZU@\5=64#`;VJ0;L./\24,?8_T7)#L7V6'5@._" MBFE"#IGZP8]?*-NG"KKM@R"M:QJ_KJF,P%"@L;VJC(AG4`!\6SG3DP&&D)=J M/;)8I7,T"&Q_Y`XPP*T=E2IDFA)9T4$JGO\Q(*R+.I%X-0FL-0GV;&_L8S_X M`,N@9H&U88&B/\HRK%E@;5BP/?3\T?@CBD![90NL#0N(N]&.H$Z&M4G^#R&C MF@76A@7;8]\?!N-1;VL8:YC&K,\A+CM1$K@_"&%<$00T_:@/4E!0[< M-F;S'@:W,6'[1FXP&;8!V_=(WJIUP*J37]#U<[^N^Z3!X">RWGP*!NU[+PT& MIO.$Z52WZD6L>Q&;7D38B]A>0[0\`L&W>Z3!Q_V+].UYV&O%6\:`@MN-T>"N,9TG9%EC_$IW1_.J M';3=H.-)3WS3$P][XMM_QUNFP-YUNRD:W#6EHVMI,,TL!,&HK7MU'N]XMKX2 MVUR)A5=B<-KKFDT];_)E MM?/NN(+3M_J9PLL6A6W9M0&<<*Z:"_V><'I]6_P%``#__P,`4$L#!!0`!@`( M````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_; M-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7 M`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA M0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD M$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G; M`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG M6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;G MUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQ MC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J" M2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$ M'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?7 M85;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&Q MMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@! MKTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5 MA@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[P MX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0U MG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO M]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_ M7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'` MB\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R` MY+<.5%X4CO7+=US0V=:.:%BY'^XZ-U-="U56*',]N/0G>D;]V5_NWXJ]_< MK9*M[WY^=MU$`T2X&NG/2;*\;;56SK,;V*OK:.F&N#*/XL!.7Y;`U;`%I?!>N`RM(5IH3 MK<-DI!O%*2V]\F$VTF]T+55Y&LU`XO?_6D?)-[]-_[S[X[MW[7]^_126BG0@@!GH]B6,?@DM MNH9@@'KTL_'=ZE?MB^WC3(?H.9$?Q5H"+T,_=B:T`S?]Q=3VO:?8HY_-[<#S MM^EI@TZPP,A^%WAP$YULI1(N*^>)V.0Z#8B&H%.7SO`Z!5#)II/'=;)_WJ.3 M(*M7+>L4^PFRF!;']6I,UFY<[-CP%%F%KS@Y\>)II%L6EX4OU M`.IPS5K10]<]TK_[%GTN$2<7'M`:\A@;/U<8F3S?+R8FW2X-W3@SOL,<*7'C MT,*!EGU_W"XQ<(>8SI%96^GO*GZ]B.UMQV##EUR#5>1[,V*QF++I0I:NIS68R;(X`&I9T_X90!\FPVGS3*?#8=.@AH5/PZ#O>_1I&-3"?]/&;)IU M6+,ID@6>EG@TO6]?]X?#X:!S,Q@,AF:W8YK,R$]91'OAS-VX-.-OS$R[#'I@ M,.P.AC<&B+3-`1-U409=$.CW>H->9VB8^)\-Y>=GT+1->[IJKW(,%'F58Z#( MJVR&V6H@\V<]!8MMQ7V58Z#(JQP#15[M-YR!^\J]RC%0Y%6.@2*OLKI(@WT5 M-2;%?95CH,BK'`-%7FUL\IEEX*%RKW(,%'F58W"R5]GJ"NNYIRB>H2J?EYI1 M>]\=YY@Y19[BV?ZFT1+_/L4)0EJV..[F6>M@5[M"]E[_ MP8QDVVK%.1N&A9!LY5L6,EKDO\Q]DBV8JYFG)1L@)O*0D&S1A(YE44]61ZZ% MG(Y<`TD=N1:R.J+K[.MB*ELLVO/ MRB9[+%K91M:FN?&07W;ZQL2@#YM%[M&THL6NGA4-]FA9T4)61S%N]FI<+/$I M/>]A\LK>PL_?1@."TH8YGU=)L*QC5&?Y;$#!^.2XOO^91HR_S8M!"O61\=UF MSFU<8C>9=O9H7Y2^H@B9?4T'IO0`!`\U,@XVTNSETM]^6@=/;FRQ+68F@IVE M8F=Y-&$C:7G\WO<68>"R"H^>POP01XGK)&P+G-5E#_'I'N#3R8!D^)PBWSP@ M'W:2ML``"T9@,Z1J#BE'W2X;(88*$5"_KE$(L?D6@HBSZCEH?0+ M^4>TM(3T>Y*9N7R+0"_-C(,C!$X2>2C%JDHQG-O1TTH3X."("2R,NLT,>9U# M.5^90;BD"PZE19`&CEFDN:CD#HB&8IR",P1?L$[PGA!%2$0?P4=(KRGD"W=>IFH*J#,E%@Z$J M1?(<5.7(,AH,52F2HZ`J0_*>4)4B>0ZJ MKI[2E2-\P=92W%*:=B#MO':J/4>Q]RL6F?18B(-BJAOK]!A1XCG\F5]B>_GH M;K`433=&-O/#M5XPR>L;KX-19'B04RD?A75=JR.\?"N2JV+4K'$443A#[J8JG3B*3;)R M8&4>Y:-E=Z2M/=(UZR&V^G2S]_]1(CZKG-UZ<)2;J#UW\M%/>0?N[E06=:%EQF74*=?;:/6L_ M\8/];5]XLP4CEHC<#3?B[3;%@E*CYY_Q3H+V[[0K[;U#(P6,DXXY'2HPK#T? M]U]31-!BW\'H'@63]&2V/#N&A85QBF50"8_#0C6M+A80,BPJ`'%8F&;6Q8+X M%*L+;3DLW(M4&PM%N0R+RG,E+Q-3\+J\T"3#$FW?D[2]N<^/K)!=\B*597CQ M6*4?J0S*84'ENEBE'ZF(QF%!Y;I8I1_!D,,R(:0N5NE'>(''0KC5Q2K\:,)Q M'%9/TO8W>_THQBI5G61X\5BE'\58[4K&*H]5^E&,55*Y+J_2CT#E[&7B0EVL MTH]BGC`E\P2O8^E'T?8]2=N_SJABQ!N2$9^BE+[#-\Y&>&Q;RD8I2NDU,HI3^$N/;E(SO%*7T%/`XC4QY5E7#!A#TB1X M>XVS]O%6H8C>2<2JJGCP@E>(]M!D%)H^N\Z+-L5-L@60V!]H&)4!>M@L?3NT MDRC>:E1)+>!$I_9/,C`?PN6Z\)"82VGHEH'XZ(4O M[DR,'-'"!DC*('URUTEL%_$G=BE#TC"?Z-;J`D-,$>Q.Z==SQD^XDSHW(DWW MN61`.9W_@*-8B>\<(V]&`Z[ M11WS=N7CM6QQIFQ&_G-Y;J1S!RE]]B@):*-^FBO16A4OK!O_%P``__\#`%!+ M`P04``8`"````"$`7�YJ\/``"K,```%````'AL+W-H87)E9%-T&ULS%O;;AM'$GU?8/^A(7AA"="-DB7;69L+BJ)L)A*I<$9)_-CD-,5)AM/, M](QDYS\_ZPY[_OM_UQ*5_7F\M9?,? M%N[0UN'>UVM'7*LDU*200)S+U!G<@A:[R`6J^GNI3#-37_WY!^5\ET_QC8ZR.)7)`[2"I9UNSP>Z M/EL^\EL517L_Q/H>:E#2P`4#T3XJS59?GUX;ES-$WQ] M7%_]9M"Y.>_[O7/1'0[.>P,/G\XZEYU!MR>\][V>[XGM&^]@-?=#P/4SBMTLSJW_DZA=451M@Q1J6.`FR?YK9BQ/^Q^]7YX>=X;><]%[^N;OO]!;)_W+OK=OK_S M15VY),D;H:;5J?8OG:AI.0H2*"6)&%@$$`A%D M";EY.E,B4'>&%Z(X75OU/'[P\%:E1QO3`B.7K[:V+Z< M,#@`->I]TQO<]!Q/R;^O*ZKWW35AH^?T?Z=B11&7,AP9S,.8,XHTO'..YG+H M>>*L=S$<]<00UC`2_4%W>-43V_GDCGD^K5>)5KV/R-_?`+,DAB`\VJI#: MF:D?3Y`B&R6V`V4_[?#H1V+-^F$<@L(\!-451/ON(GHB*!L5[(CQ@VB2MSZ, MAUQ$^MZ(::+GB'!WB&^$K8_HB`=>)_HN1$9.JS6-?&RUBS"6\>21U;#(1*D@ MW^!D*6`)"C>8P/&H(L!,4#4DX3A+&VJ*U6ECCM5KPG^IVV5YF_9>EY<&5N>) MO(@-@LV`]%?OSCJ5J3A#^1''I!;8M4W;UG6E4F%SIX4,5^(EG(!J#-1:#19K MTYOZ8A!!SY7PY4]-R"`KPR`H?(K:O)NK MJ\[H`X4"K_]NT$?NTJ&4L=L=W@S\_N"=N!Y>(I]QH>KI(QWA!T._)UJ4T?W& MU1,J;(?)K8S#GP`SR*KVK"+10'^N\8_YB3(K5.6MK8/VFXF.=$))S!QE.'^3 M7,!B;9>NC,)Q$E*_J9R'T8/]^HB^X+IO#_>%7\TJ9I@QUBE(@3E, M9()9%Y&,J>19((&;A`L8#<@%@F4=&X;4T*!W;``K";I)-[^CR6C+P&$T3D.: M#:C<\;K"UXMP`LO;%Z];)ZL[694MU=@`8Q=6N%/0"XP6+D%9*-(L[(LQ$-,N M``S@)U!@/M"0*1)7%`ABG!DLC,SU#JT95;'WF&0FYO)!C!6[B[R38<2=TUFB ML]L9ZP_"HN:#V(1-6P_D7#D!9C M,AX;A(F:I#HQ^[_\7#\`S&YG9FN`>:7A'*D]'0MC`ZDR0#@,0"[8V5:_26<8 M;^6R`Z`5VLPT(\'%?1A%.`=D&#"9!3;+;1;8(6:BD&HG#!"E#76+`R3P0O<$ MO2*8$_8VA4I(C-)S2A:(W(OH*=>VNQJ6BORF!!5DOZ,;MGVH M""6+%96P')9*P0Z;0YF2YAJ9R3L8DU(PM$3!^"`$8BFIL%#2?8B"*T/YDP5A MN@\TY588>FPM`T<3H^HA67'2.`L9?)^9U,J^;:T2KA9E`=PVAA4#+L"70.43 MT""TL:4!.R)65)`1L<$^`OS@4PD3C%P]V84V2*%TO(NI3!:Q)=>=F0/`E-,+ M&!'R;L@]QGD7;!T;+\B+(_Y`#DAKV!!EZ#,J1*+\`"2%GN8R4`WFD;:[*DDE M;#.L>,1\5IW"V*U#(;5C;[5*@$RY:AA"&D^H/!=,3>>9!)1QP.S3&?^<`1V@ MQ!S/(B#!KP,8O015W9)X@(7GZ?Q4A^X:8L`&VJ<1"%:E(: M'P)02*\HBH;E]OGY$[`(F4U^KCGK8ZT5VVR:O,"H9K.I&X$]_XVF`Q3"7DO3 MI5@9Q@'T2M56$;CR,(.C*M8M5IIF\)H'L)JY656\<[=SW?<[EX))%8LB:QJ; MTXDC@,^&.0C2VM!C28G:)0BE_O!\88^0AB,[1?5=*)3L#.A0&4](+K^4[ZS$ M*,[-80`.180\@@;"K>Y"G1GRDI*%0%A-Z=+`LDC`SI*;8IMA(A!!>*D<($LT MTF:=TW4`>HL4S7EULPY5R:@O8PT363A.$-(<7Z.$*41UJ>-4L(?-C MRQS9[RKB"TO/%3*^(/0L9,R3@:),(E?(E5HWYE'O$@S,N0`C!;[0'W4&7J?+ M%,S3>S;[P#%\X*FSLT-+[B"(]3K4/K/-G#`R&4Y["*J(7HL MR'20&R#WT_>4BBQ%9P+!#"G"#.TSJN%1,TEDC+A=X,0O0"PT2!M1I6$/Q.DC M38LU:'DR1$7#EV9KP$SVV`$G"OE%AW/6O\,Y-P,W@(=BF(PS2F>192*,+4DC MQCI)]#U4_\Q>BU!E*(O&%(A*<\`L;B*, MS<8-RJ2^S(`1V`"RH^8-\#4+9ZO/CBR>,QOWY+VLW0@7A$4DIT1[W0Y^T[)/ M5`'6/5ZW+@Z%;I=^G;B/K>ME*,5CMDJ45+@MHM('12I*)?@;_>4+/20UEO`B MJS_]&T=.L!/9G/VNN5[);P++D9C75*L1R_`,(IV>OMRORLX2H]/VNR'15[A1 M[?9&`^LJ54:YTNA$TW>:?+:K47TD,4@.]WT`4U@O8/8K$]57\8%#OZDPM2D@ MLF94)0__VP)H-Z=/D&*B0@1'A'*-/H?PW9P!6?$TE[D,=J@$=N6@Y'#MRP%]!U1D4*KIWO@B)`5;C+`$P!2CP4^=.,.!UX`HTJJ?I*+*QCJ:E( MRY@"0364LFJN44E-RZDXD8DL$BB6_PMM9FI>-%JGH>'',$+6H+V$+J*PM M!4$7]TXM65YS-=YOL>N>P'4W=R/?G>HBT`)\7^_,% M;CZ@%;K/JLJ".K`T!\\+/F60_K-$J1S**J2Z@F\6S[%62O,:V&R>>T"I?Z7?C6ZZJR;FUO201.8CDOD5R5R907T3BT@+\`-DMNR,5FO4^7$[F+P;$ M-J("T=0Z<2YCG]EM\:ZW3W9?GKS:W.7E[JO'NK1>[AZ?'&V>IO5Z]^3([?.M M(F.%!8`P2\`+"FR<&#<]K9U@NC^Y`8V1(@(4 Z'$0P55$UM!8JF,6,7@)=J>LY4R=:[>=I+^3-P M)1>%J&9R`'2OLPB:FDY!:[`/82+X3!ER`MI8 M'C8J!W)<)\UL7>?BL^?_HG;I4?ZDHM7XJ&FA$0(@M@% MQ1J(2.(AS!&US09/^AA+7*L`5OD]I@`N$,)6EP[Y%VNXOGO%`%V^W`EP^X`8 M3_E?!(5\?OD.W%#BV@I*M(*+AMDYL7VNX'=#1,>V&WG6C6KY: MJ[?!Z7/6M(EPK/?NY$AY0TB)8$OJMDC),'(-=^$',F+;)XAP-_O$\?5U5S!U M72.!8KT-+R.N;_CB,/F'],S MF-)]<8CZCMA21\UYMN).[/0LRWGVQEQLERLEPRVY4GS.`9!#5GU._U?1IO71 MY`R\#;IM=I^5L9\409)";_''&\UXZ<'I MX>NZ`"O\^\JZ]42H/<(U!L(0D)9B8LX`;!1J+;'YN$QL,>M>R8(P*)^T.V^I MP6B4[VL=6UN[(T?:LX+^N*"'/W+32]9._?WKB"(,F4:'RN6ZRIWN0UNO+MG$ M`?ZS0?N_````__\#`%!+`P04``8`"````"$`'7+C1GP"``#3!@``&````'AL M+W=ON39"M05. MHA@CWC)5BG99X)\_'JYN,#*6MB5M5,L+_,H-OIU^_##9*+TR-><6@4-K"EQ; MVXT),:SFDII(=;R%GDII22TT]9*83G-:^D&R(6D+@,-:7>*BJ$HS? M*[:6O+7!1/.&6N`WM>C,FYMDE]A)JE?K[HHIV8'%0C3"OGI3C"0;/RY;I>FB M@=POR9"R-V_?.+&7@FEE5&4CL",!]#3SB(P(.$TGI8`$KNQ(\ZK`=\EXGF,R MG?CZ_!)\8PZ>D:G5YK,6Y9-H.10;ELDMP$*IE9,^ENXO&$Q.1C_X!?BF4F&@"`;R2%VQE0$/KB?S>B MM'6!!WF47<>#!.1HP8U]$,X2([8V5LG?091LK8))NC49`/VV/XW2FRS)\G^[ MD$#D`]Y32Z<3K38(-@W,:3KJMF`R!F>7;`#U>3\91')C[MP@/Q34!E;C>3K, M)^09*LBVDMFI).TKYN\H1CL)`;P=(R0_9#S/YL20`:,]V_7.UN//@F1X*.DK MYN<4/328YW(T)RXP>._1;OH3SX)DY&N:?+H:]+OG?^WN04&RRZ&<^`AJOPRA M7D&2>Z@TB_WG".RLI`<'&_YR."?NPV5Q?^99D`2X)'D7[JRD!Y?_#YP3'\$E M1W!!B-:CA%>RD.+J&@#K<2J%A5>>/YT)9N$W\ M8PTO#PYG-XY`7"EEWQKNWMN]CJ9_````__\#`%!+`P04``8`"````"$`>S_] M8;,#``!R#0``&````'AL+W=OQ*N]+1T?FX=L!)K`)&V&W:?[]CAA+L)(3VH@WU MZY?',_9XLOKZ5N3.*ZLE%^7:)1/?=5B9BHR7A[7[[S]/#PO7D8J6&>25_'`KTC%V M!:V?7ZJ'5!056.QXSM5[8^HZ1;K\<2A%37E_P63O8O93DX&_:B=C>_J2J[_%Z3OCAZ."=,]A M17IAR^S]DU.PTG\\B?$I`[ M.R;5$]>6KI.^2"6*_U%$6BLT"5J3*="WX\$D6,S)/+SOXB%1L\!'JNAF58N3 M`[L&WBDKJO<@68*S7MD4XG-]9;`D/>>;GM1,!;6$=+QN@L7*>X4(IJUD>T5B M*I(KBKB3>(#7,<+*^XS#;%H,:W"=CFWJ=[8-_A8ELYYD9BJ2(86!!N\9CZ;% M:Q>\SVC$?/$6)8LFIO/@'(\&/.F/SN;^O)ML,,'"QC-IL<44=+88+I3,;C#A M:-B,WF:";3Z>28LMIJG%A));3#AZCRG\#),66]O*VC1;E$`\NO1:BF1(8:0P M^@R:%EOA.N\,3"%*,%S6:4BNCQDX^A[K%8GA`ZC%%DYH90\EF!_BAV%DCB?] M\2B(SX?$H(H_0Z7%%I7UUBU*D&KAPX]%U1^/C'$#BT#Y'!^M1FV!7=12[;AV MD2R^$J_6!`71[8@1J]H/)[)16VA61=JVF@$T+//WT73)';W'"!9HJ(?GLV:E M:]MJAL[CH,1,JBZ]/3Q]3X;W[TDLV/V*/SMO9CR:!#48($(NM]V`P$34E;B' M>">Y6+<--+OP$]2TR0VBR#K'R8#`1+/*_\@NX_(>F-GW@.["NJ/Q0.)I3.RB M:TFB$/JE[F2;F)^Z$0A6,365%#^P7K0^\E$[.]G!(_$D$*:JQ9\8' M):JF>=P)!;UN\_$(WVT8=);^!,1[(=3'@^[*NV]+F]\```#__P,`4$L#!!0` M!@`(````(0`A"J6CNP,``)$-```8````>&PO=V]R:W-H965T&ULE)==;Z,X%(;O5]K_@'P_`9./ME'(J%!U9J1=:35?>^V`DZ`"9FVG:?_] MG(,)P2:9);U(`[R\Y_&QCWVR^OA6%MXKERH7543H)"`>KU*1Y=4N(C^^/W^X M)Y[2K,I8(2H>D7>NR,?UGW^LCD*^J#WGV@.'2D5DKW6]]'V5[GG)U$34O((G M6R%+IN%2[GQ52\ZRYJ6R\,,@6/@ERRMB')9RC(?8;O.4/XGT4/)*&Q/)"Z:! M7^WS6IWG]2K+8028=D_R;40>Z3*A"^*O5TV"?N;\ MJ'K?/;47QT\RS_[**P[9AGG2;/.-%SS5/(.9(Q[.R$:(%WSU"]P*((AJ!!A$ M_7<*\QAB%+\+T_]^"OG<3-L_TLOXEAT*_54?HFHH"+.#3*W-<3Y!&]F;H\DSO(S)=3.9WP92"W-MPI9]SM"1>>E!: ME/\:$6VMC$G8FL#_HWD>WFXR;4W@?VM"P[$DOAE5D[`GIMEZ)<71@^4*W*IF MN/CI$HPO9P72@=I'%$?D#N8M(@JFYG4=K/Q72'[:*F*C@,].06U%-C:)/ M=F\KDJ'B"MGB%C(4VV0/=MS8*.;-VI_1^0*&YZ7H_<$%#ML3NG%1F*QG6O/U,!0;423*4G$VL*J!PHO43AT?-%.[]SZ:*;SF43B'&C7-$^IAG!I/!5K)HEB:E M0?/7K5Z;$_?@T1-,S8[=WTFHL^SC5M/GHV[)7M"AX!WR#^AV> M"Z%30]@YHT]_#"Z?:7A-_U9RN>,)+PKEI>*`#2R%TN_N=AUYVRIW#Z"WK=F. M_\WD+J^45_`MO!I,[B#+TG3'YD*+NND.-T)#5]M\W<-/'P[=5C`!\58(?;K` M7J[[,;7^!0``__\#`%!+`P04``8`"````"$`=2F]ZNX"```I"```&0```'AL M+W=O';`@%7`R'::]M_O&@<22-MD>2#8/CX^Y][KR^+NI2K1,Q62\3K" MKN5@1.N$IZS.(_S[U\/-'".I2)V2DMTAI6,BXHH&(K["I:*T,B:$D4Z)<%:V3'5B77T%5$/.V:FX17#5!L6#,_J*)8)+GBD+Z&PC]-SSK7UK`]-RD3)PH,..!,TB?.^& MFP#;RT4;GS^,[N7).Y(%WW\1+/W&:@K!AC3I!&PY?]+0QU1/P6;[;/=#FX`? M`J4T([M2_>3[KY3EA8)L!V!(^PK3UYC*!`(*-);7RDAX"0+@B2JF*P,"0E[: M_SU+51'AR=0*9L[$!3C:4JD>F*;$*-E)Q:N_!N1J43V)=R"9@/K#NF=Y\\`- MIO_!XA]8X-R.);!\+YC-K]!B&U]MF&*BR'(A^!Y!Z8%RV1!=R&X(S%U\C)L^ M8N\%#$QJDGO-$N$91A`+"4E^7KJ^M["?(3/)`;,ZQP23(63=073P-&]L)N!Y MPCO:M'D#T]/:X+*W"FDXM?IV"72.-%@[ZJ2LS,2IE)'!]3DB"'HEQL]ER.8< MJZ7H[&@RU.PBD/Q2W,A@HLS[8(\3Z(B*^B-A\A!CX`R&G_G1E^N_> MW"YM>E.$(8:]!]%J3>-'4Z'#E8&,S47T77:WQ"RO@R)+T.@O!7R2*;08QP)PQKGJ!OJ`_B._ M_`<``/__`P!02P,$%``&``@````A`/N/$8;C`@``30@``!D```!X;"]W;W)K M&ULE%;;;J,P$'U?:?_!\GLQA%Q1DBK=JKN5MM)J MM9=GQQBPBC&RG:;]^QUC0B%IT^Q+")/C<^;,#$.6U\^R1$]<&Z&J%8Z"$"-> M,96**E_AW[_NKN88&4NKE):JXBO\P@V^7G_^M-PK_6@*SBT"ALJL<&%MG1!B M6,$E-8&J>06_9$I+:N%6Y\34FM.T.21+,@K#*9%45-@S)/H2#I5E@O%;Q7:2 M5]:3:%Y2"_F;0M3FP";9)722ZL==?<64K(%B*TIA7QI2C"1+[O-*:;HMP?=S M-*;LP-WF[I@,_-$IY1G>E M_:GVW[C("POMGH`C9RQ)7VZY85!1H`E&$\?$5`D)P">2PHT&5(0^-]>]2&VQ MPG$8S">3\70^`YHM-_9..$Z,V,Y8)?]Z5&.I8QFU+'`]L$R#R2R,(Q#]@(3X MC!J#M]32]5*K/8*I`4E34S>#40+$;SL"*PZ[<>`5GF$$N1IHP],ZBL=+\@2E M8RWFQF/@\Q73(0B(=LJ@=KFR`SME5UN7RHT/]&5&;\O$_R/CP-"2S`P")#+#3HP]*!/&\73(VD/ZF/>D89YZ$N[>8U#&/OS[76GFARZ M*K<1*';7S<4[=9X.)<\K.?!0J8W$S7/8'Q.8MKZ5\[P.?%+%V5$5/>B"*KKU MW7LVFJ=^_F$5W:FAMS8RJ&+<)368F<50\KQ;!QXJM9'3*D:0]K&7T?A#+\VQ MH<0AU'](%N^,(>SD@>IY.PWZ2*S=)CU#?DG['2:YSOD77I8&,;5S"SB&K=1% MNY?#9N3&ZC@^3C;3M^*S9.-?)J0[`[B!C$CW1V#]#P``__\#`%!+`P04``8` M"````"$`/=DBO]T$``"N$P``&````'AL+W=O%21[6Y1P?\GA,$\%E\IJ+HB8GI5R^O%X>$IE?P,5SFJ7US\:I:>3)^ONID&7\G$'<[VP9 M)S??S9\[]WF:E+*2QWH![BPB>A]S:(46>-IM#BE$@+(;I3ANS4>VYHYC6KM- M(]"_J;A6@]]&=9;7W\KT\$=:"%`;\H09>);R!:'?#W@)%EMWJY^:#/Q9&@=Q MC%^S^B]Y_5VDIW,-Z?8@(@QL??C)196`HN!FX7CH*9$9$(!/(T^Q-$"1^+WY MOJ:'^KPU77_AK6R7`=QX%E7]E*)+TTA>JUKF_Q&(M:[(B=,Z<8%]:W<63N`Q MS_^"EV7K!;YO7E9SJ5@45J,2C^MXMRGEU8#2`^+5)<9"9FMP?).'@ND$&],+ MA$(GC^AE:ZY,`Z2H(,EO.S_86&^0EZ2%1/<0IB+V-P0F`;URN@"?G5=OV:VQ M((`N"A!X&,7'R;V113"2O>T3T87A/DZW3<-D?X_P/!7"[R&]$X4K%,%\K@B& MDAM(X(?JQA%!('>=2KU(Q/Y3!)]"*.1AF_GD$;PU09B.V-N*N`T',T`-<`;LCZ\!7J<+O.IXY@5?>55JX106#[+KI^8^+^*8)/(13R MODH>;U,7>N%TH>,B37]-O8@@RT9_+3?[H2T,5VKF^-#:KU1(0S^8KSB"-;*N MNF5$$+\AZ[HK7S7OAV;'L[50^=#,;-_O`U)(X^`?-,1IA1&LD=:*("((D7Y@ M;GA'6P7XMJ.%S55`X#K+$>KA5Z@C6*MPK:5%!)FJ\$\1?`JAZ,Z@G(?"SROQ M9I66`:TNHA;S<9%/&?F(4>6-4VIVP3"::<.&ONJSV;2-J,5,Z?XYA$]"U`AP M=,V/@`:=TM7O9CUA1A2?,')&1KI=ELRV1UH+PXDUGS/--X6S/D8;CUMSA/-M M0.*C34^IR1=O5Q)GWUD-[G!59QQ5\SDC6JWL0-LY8H2AG5$L#;!7`/#FH0.X M`@@4@,H=)]6`^\R[D^;;4/=`'Z/X,`YQ3L0P!'P8PQ#``G<\`3BS!D%,]W9& M$TXAK\V4J,40^8KZ) M^Y21CQA5OE^:H0[-4*52M/LJ:C$C?,G!AT8^LE+E"WL/*V1>-X1CCKN.KD_. M%D,O1'HWGS+B(0IZUU<2;SH>H1?_7)0GL1=95AF)?,6C#P>>J+NKW;',8W,J MHUV/V!K>T_'`I3/`:89S,0%O^O8"P$.WBFTE;VT@T;RA%O(WM>C,GDVR4^@DU8_;[HPI MV0'%1C3"OGA2C"3+[JM6:;IIP/=S,J=LS^T?#NBE8%H95=H(Z$A(]-#S@BP( M,*V6A0`'KNQ(\S+'ZR2[21),5DM?H#^"[\SH'IE:[;YJ47P7+8=J0Y]%"<)@7\2P!.-IP8^^$H\2(;8U5\F\` M>4)`/B?4Z!8'?`9#J?L(%&UHZ>)(3R^FBN\7V8&G2GTD3/)X5F#B#IU\V$5W M:BK01V!X_ELY,C=N&X\^F/>M./!4J8_,_*886UE,>?V'>/6A%7=J*M!')E9F M;T]@`O2G>_'HJ=8^=.@&]NB$VME)YQ_:\<=>:?2+8_+1O1[LL'/#8I-<5_P+ M;QJ#F-JZ?9K"1AJBPZY?IZX'K^/S;!W^`61X`SNXHQ5_H+H2K4$-+X$SCBYA M_G78XN'!J@Y2ATVL+&Q??UO#WY;#6HHC`)=*V?T#*)/A_[WZ!P``__\#`%!+ M`P04``8`"````"$`T;%\*"H%``#Y$P``&0```'AL+W=O:0ZL:;=A_6\?'P^)SA:(;FYO-K53HOM&D+5F]=,IFZ#JUS=BCJ MT];]]C7]M'*=MLOJ0U:RFF[=-]JZGW<__[2YLN:I/5/:.7J^?,I9=0&*QZ(LNK>>U'6J//QR MJEF3/9;@^Y7,LEQR]V\L^JK(&]:R8S'B+:9M#1H%FXL\Y4\Y*$`#_ M.U7!2P,RDKWVK]?BT)VW;K"8S)?3@$"X\TC;+BTXI>ODSVW'JK]%$!FH!(D_ MD,"K))E.EF2Z#I;WDP0#R4*1D&`R\^?+52_%_GI/6.DS$V==MMLT[.I`N8'8 M]I+QXB4AL,F4"`:5I'_+$22'DSQPEJV[=!VPW\+&ONQ(L-IX+[`9^1"S'XG! M$9&,X)GGM+$))":0:H`'CI0MR.[_8(NS<%M2T%X"-Y^^X4%&R"6Q"20FD&H` M\@";;'H(H.;'JU7N!%\$=8EV8HTU[D6,#UQJNV8X)%(ARH>%)!:2Z@BR,K.M M\`?O!ZN,LT"=PHO230+3G`CZKCD5HLQ92&(AJ8X@A>OE]K/!A+%@A(EFHB"XDM)+&05$>0 M/F@QNKX/MBO.@H5;2#0@:SW[LRG.?JR"I-]$(=JFS0A>EJH@6(;L\9/&?^_& MG`7;LY!H0)`],L.(+`UOHT'&S$I4$!]I_M1\^E+S\]LT0-M*H-7J MQD<,P@E".NRCL<4!TCQ:2&PAB86D.H(5\D&J5=X["L78A4XL"V-/!(2;E=&; M(Q4DE\46DEA(JB-8-)^<]XL6$2&=0ME-K:AQ(92!&'A?%!J MPD4;^\$'@8AIB_P,`U@O?-]H/I%'26^`>%?%C!&]VNG"Y3CY"B1V4(@CKYI/U?MUB#B/=PVA&Q6/TU@@$6[HM M*+&C4@1AX7QFWB]\F+!Z@Q(03KC1[R,RK-,3;D&)'94B"`OGTU`3_K%G?1BI MNA\!83]6PQW6K<1O,C+M_^$JB\D=0D[03@O?'9J>7GG.1\FK9X``?F! M]J!;4`SW";P4M:C$AOBMPRU*R!2W".*W"Y-?!["@7L$7X1PT!W!R5K>@YA,RW"_&ED1+4,XBMI,T2J$,YR- M)\L0SJ`C^"J$PYN-P\7,0W_V,/7P"YN1^+T?PJ]:FVX?````__\#`%!+`P04``8`"````"$`)3Q8ZZH" M``!*!P``&````'AL+W=O-*8,FZ](7/B['Y]QSKWU9 MW3S)"CUR;82J4QP%(4:\9BH3=9'BGS]NKZXQ,I;6&:U4S5/\S`V^67_\L#HJ M_6!*SBT"AMJDN+2V20@QK.22FD`UO(8ON=*26GC5!3&-YC1K%\F*3,)P0205 M-?8,B;Z$0^6Y8'RGV$'RVGH2S2MJ(7]3BL:\L$EV"9VD^N'07#$E&Z#8BTK8 MYY84(\F2NZ)6FNXK\/T4S2A[X6Y?3NBE8%H9E=L`Z(A/]-1S3&("3.M5)L"! M*SO2/$_Q)DJV,2;K55N?7X(?S>`9F5(=/VN1?14UAV)#FUP#]DH]..A=YD*P MF)RLOFT;\$VCC.?T4-GOZOB%BZ*TT.TY&'*^DNQYQPV#@@)-,)D[)J8J2`"N M2`JW,Z`@]*F]'T5F2[,ZGJ_((]2-=9"MA\"UAT0]@H!F+PQBEPL[L!-VA769;'U@*#,Y+S-]CXP# MIQBN??+QHJ?UPAXR&T!F/6+D#R"7^W-@Z,"0]J2R'C.$_$,9=M3ER@[<*O>E M[2)0X;]56)[WN'B/D@./E;K(M#UYP[T!.VSHH#UL(>3U]NYTJ\8"761DY?J\ M%3>G+SX'#CQ6ZB*G5N(QK[,2P_1YVXE;-.;WD6'SX_B5$3^[_.&67!?\$Z\J M@Y@ZN+DT@>/:1_N1N9FXVK^.SY)-.TI)_P%&64,+?D]U(6J#*IX#91@LH2?: M#T/_8E4#><-$4Q:F6/M8PC^+PY$-`P#G2MF7%Q`F_5]P_0<``/__`P!02P,$ M%``&``@````A`(L?M2&=`@``U@8``!@```!X;"]W;W)KS$D:=*@D"I=U:W2)DW3?CP[QH`5C)'M-.U_ MOSM,*5FS+7TQ^/CN^^[.YV-U_:AK\B"M4Z;):!+%E,A&F%PU949_?+^[N*+$ M>=[DO#:-S.B3=/1Z_?[=ZF#LSE52>@(,C6O$7LO&!Q(K:^XA?E>IUCVS M:7$.G>9VMV\OA-$M4&Q5K?Q31TJ)%NE]V1C+MS7D_9C,N'CF[C:OZ+42UCA3 M^`CH6`CT=3OL2$L*\ MTOSI5CH!!06::'*)3,+4$`"L1"OL#"@(?^R>!Y7["MZ6E&RE\W<*J2@1>^>- M_M5_["F"\Z1WAF?O/)U'EXMXFH#6?TA8"*3+ZY9[OEY9-.F2[BP_^Y0]#H6Z"WC3DF2^'0N.*7/O@P(/I8*EME+*F&.A/NFI2WE M!UG7C@BSQQDQ@1LT6(?QM9F@_Y_V6;KIQAH;/L!8:7DIOW!;JL:16A9`&4<+ M.#L;!E/8>--"E#`?C(?!TKU6\/^0<(GB","%,?YY`\)L^".M?P,``/__`P!0 M2P,$%``&``@````A`%W28K&5`@``W@8``!D```!X;"]W;W)K&ULE%5;;YLP%'Z?M/]@^;TXD$M;%%*EJ[I56J5IVN79,0>PBC&R MG:;]]SO&E)(EW=(7@P^?O^]/V M[((2ZWB3\UHWD-%GL/1J]?'#(.MZ9DMC7`\^Z0JEDRF2R8XK*A@2$UIW#HHI`";K38*FA<(#%0BI+\9F!#^U#UW,G=51A-$7LSC^0+Q9`/6 MW4K/28G86J?5[X"*>Z[`DO0L^.Q9IHMH?CZ9QO\G8<&C+L`;[OAJ:?2.X*5! M2=MR?P7C%(F/1X2A>.S:@S-Z3@GZ:K$*CZMX&B_9(Z9.])CK@,'U%3,@&(H. MRJAVNK('>V6?6^_*=3",99+C,M/WR'AP1G%]=?X@P("9C3"SX\H(.3U`#\8: MC&D/,NWZ;WP]\):- M0_`M=XF-^^\+Z@_M\_>6_9).CQ?,3^N3>\&#]Z6"9?8:29@GH=T4F!(^05U; M(O36SXH$&VBP#F-LG?CS?]MGZ;H;;VSX@..EY27<%5W4NRHWK3Z:NP\M,[//RN''_ M^I-]N7>=NDG+?7H6)=^X[[QVOVY__FG]*JJG^L1YXT"$LMZXIZ:YA)Y79R=> MI/5$7'@)OQQ$5:0-?*V.7GVI>+IOG8JS%TRG2Z](\]*5$<+JEACB<,@S'HOL MN>!E(X-4_)PVP+\^Y9>ZBU9DMX0KTNKI^?(E$\4%0CSFY[QY;X.Z3I&%WXZE MJ-+',^A^\^=IUL5NOUCABSRK1"T.S03">9*HK7GEK3R(M%WOT/3;'B%P]BQO MUE;@]\K9\T/Z?&[^$*^_\OQX:J#<"U"$PL+]>\SK##(*82;!`B-EX@P$X'^G MR'%I0$;2M_;S-=\W)_2>!/<+?[$$>^>1UPW+,:;K9,]U(XI_E)6*):,$*@I\ MJBBSY61Q-YWY&.2*XTPYSGM'>+P_G[8/O^('45O:R\'OZ@,]*;O-8IPVZ79= MB5<'EB;HJB\I+G0_A&!=^N2C^X3^5SXAD1CD`:-LW#O7@4S5L`A>MK[OK[T7 M*%RF;'8C-M0BZBRP2A@V-H'$!)@&>*"HEP6%^`19&`5E=81V'3#H#`P-G47G M$IM`8@),`X@&6!N?H`&C;%SX_TIII$T`FZ\WFANZ>I->F(4D%L)TA&B#]?X) MVC`*+%SXZ'G;ZTX:7177F_3B+"2Q$*8C1!QLSD\0AU%:<1VIG40"6/.:7',! M]D:=6VPAB84P'2%:H"?H6L;;:M<&T)A2EH@<`.V>CBPDMI#$0IB.$'[0 M_P_J:\-0@384=1"5N*!/>T$ MI!QL1E;?#":[FO=R[D+G[7CM?`FU1SVYTQ6"IS&MBG>F1!6*6MU3JV2(A8>+ M8.H;6Y%9!D-?I$7&::O)'Y$)1[9>IYS-1*>$=)TF$OLFDE@(TQ'*$(?F[0SE MB"4,U=0E:5_1A$9^9]05,+:0Q$*8CE#2.`QO)RU')R&MIJE..IB:I)7?LE]V M,<1HV\D`)3;$"$2)X^33B']L.V`08\M+"!;"L/8#XT@-3*V`#)>"RC9[)QJZ%[T-S@U-5R\X.](F6*;2BQ(48@ MRA+GZ>TLY?0E+-5`)D4PID:$-<)2Z<0[OVX+);81(Q#EC7/V=MYR*A/>:E`3 MWD9[C7SEI_.VH,2V8@2BQ'&"WDY^\M.)6U!B6S$"$>+X M#J`3_]!>;X/0O:X@JL=LN)W?O7H]GK;_:(.+;S%*;C%B/S"B><$1?'-!\?W# M:'8*"F;#1K>AV(82&V($HC1QJFHTL7PS*.G_O*O`,[W)7T+`7^O#,W/Z*$=- M96Q#B0WA_1<^43I*2?(^2][$%+PZ\HB?S[63B6>\JX*FL5WWL+Q(VP5!=Y-F M_C(/X5T4FI")+T)XKQO!ER&\3XW@=R&\FXS@]R&\$XS@`=[M^6._K,(=G$!M MEV@5PK%]!/>G(1YV[5^250@G]A$G,3`>P'26+>1V)LYN% M<'\Q$G\.\5L'KW\"W"A>TB/_+:V.>5D[9WZ`*D[;0W4E[R3EET97:,`6L!(]O9[/Y]9S!A(=E+ M^A+"<'S.G)EA6%X_5B5YD,8J7:]H%(24R%KH5-7YBO[^=7=Q18EUO$YYJ6NY MHD_2TNOUQP_+O3;WMI#2$6"H[8H6SC4)8U84LN(VT(VLX4FF3<4=W)J\3(($#.-XA@Z,&0]K2V'C3$ MO"(-0S64QFF=P,R_W5T\U*;0%[F+0*V?FQF^4N?Y6/)M*02/I;K(I'T+AV," MTW9LY1+R>IL?#XWYN\C8RN3EQN'2/ON=0/!8JHN<6EF,>;$KBW>[@H?&_%UD M;.6508B`_WPO+7HL=@B=NH%U.Z)&._'5NZUICQUI=#MC[&AVU!R_F_WRJJ3) MY2=9EI8(O<.]&\,ZZJ/]-V$3XSP=QZ?)QG\K6/\$=G7#<_F=FUS5EI0R`\XP MP$DS?MO[&Z<;R!U6MG:PIMN_!7R5):RD,`!PIK4[W(`RZ[_SZW\```#__P,` M4$L#!!0`!@`(````(0`Y&L6Z,0$``$`"```1``@!9&]C4')O<',O8V]R92YX M;6P@H@0!**```0`````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````")=3,ZV8).&G&BWMS>K79WHE9?A__/E M.R?U?&?;[`,"FLXUA!4ER<"I3ANW:JG>Y`9H59:7 MU$*46D9)#\#<3T0R(K6:D/X]M`-`*PHM6'`1*2L8_>Y&"!;_O#`D)TUKXMZG MF4;=4[967^'4WJ&9BGW?%_ULT$C^C#XO[QZ&47/C#KM20,1A/ZW$N$RK7!O0 MUWNQ>PUMAKBMZ>^LUFJPXRJ`C*"S]![_LCLF3[.;V]6"B*IDLYRQG%6KJN05 MX]7%2TV/K?&^F(!V%/@W\0@0@_?//Q>?````__\#`%!+`P04``8`"````"$` MS#VYHH4"```%!@``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````"<5%UOFS`4?9^T_X!X;TFZ:ILJ M0N4:MT4CP+#IU"?+`Z>Q2FQD.U&[7S\3EI9L5)KZ=GT_SCT^]KWAY=.F]79< M&Z'DPI^?SGR/RUHU0CXL_(IU%=QX M#D*:A;^VMKL(`E.O^8:94Q>6+K)2>L.L.^J'0*U6HN:QJK<;+FUP-IM]#OB3 MY;+AS4GW`N@/B!<[^U[01M4]/W-'GCM'.`I!U[6B9M;=,EJ*6BNC5M9#3S5O MPV`<#!T[S.NM%O8YFH7!^!CBFK4<.N!HQ5K#P^#5$=YRUHM6,*%-%.[LQ8[7 M5FG/B%].MC/?^\D,[^DL_!W3@DGK:/5IPV%OMYVQ.OJA]*-9QK^ M!D72.KUH(H?7%FK,_.4.50:J."$HIC#/8I1A9UV!%&0047S[CI+Y?]=@`@A: MHHS@=Y1,M\'5<@G*>YI?4YS<9,EU`D%&*(`PKS(RV0:"(B$@I9CD\-MD1HE2 M1S2F!2C)/24ER#"`),FS:=XW>9+=]&I"5&:3@&F.,2U0Z00&)9I,P=451M\K M)PY%=V]*].=>?;\B3Q.8((>KW%"Y#3`)"S9J*ZVAE>&-^QD4JDVWM6Y$:*K, M=`G,ET5%^A;'M&G,+1.372#KA&4MQ5;5CY1H)@VK^S$W?=%TR?@5>O%(F5RY MMGGV9LF;S[)G-NYR-&]_35@JY*.I.J)B9OEAA1P[0[QFFC=NN`[Q5T=XZ[:' M;GL0N&;R@3>'G'\#_<*[&[9Z-#\_G7V:N5TV\H7!Z_Z.?@,``/__`P!02P$" M+0`4``8`"````"$`4<-"NZ$!```8#0``$P``````````````````````6T-O M;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P"```+ M`````````````````-H#``!? M_5D$``!O$0``&`````````````````",#```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``+R']'4`@``1`@``!D````````````` M````&Q$``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`/MBI6V4!@``IQL``!,`````````````````^QD``'AL+W1H M96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`OF4$ULH)``#V3@``#0`` M``````````````#`(```>&PO&UL4$L!`BT`%``&``@````A`/N/$8;C`@``30@``!D` M````````````````1T@``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&@>KMO3`@`` M!`@``!@`````````````````=%```'AL+W=O&UL4$L!`BT`%``&``@````A`"4\ M6.NJ`@``2@<``!@`````````````````WE@``'AL+W=O!@``&0````````````````"17@``>&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`.Z.;7S2`@``+`@``!@`````````````````)&<``'AL+W=O M&UL4$L%!@`````:`!H`Z`8``$]P```````` ` end XML 12 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended 278 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
REVENUE:          
REVENUE $ 0 $ 0 $ 0 $ 0 $ 0
EXPENSES:          
General and administrative 4,548 6,852 13,976 17,020 183,247
LOSS BEFORE OTHER INCOME (EXPENSE) (4,548) (6,852) (13,976) (17,020) (183,247)
OTHER INCOME (EXPENSE)          
Interest Expense (1,210) (1,006) (3,376) (2,502) (10,667)
LOSS BEFORE INCOME TAXES (5,758) (7,858) (17,352) (19,522) (193,914)
CURRENT TAX EXPENSE 0 0 0 0  
DEFERRED TAX EXPENSE 0 0 0 0  
NET LOSS $ (5,758) $ (7,858) $ (17,352) $ (19,522) $ (193,914)
LOSS PER COMMON SHARE $ 0.00 $ 0.00 $ 0.00 $ 0.00  
XML 13 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
LOSS PER SHARE
9 Months Ended
Sep. 30, 2013
LOSS PER SHARE  
LOSS PER SHARE

NOTE 5 - LOSS PER SHARE

 

The following data show the amounts used in computing loss per share:

 

 

For the Three

Months EndedSeptember 30,

For the Nine

Months EndedSeptember 30,

 

    2013

    2012

2013

2012

 

 

 

 

 

Loss from continuing operations

 

 

 

 

applicable to common

 

 

 

 

stockholders (numerator)

$      (5,758)

$      (7,858)

$      (17,352)

$      (19,522)

 

 

 

 

 

Weighted average number of

 

 

 

 

common shares outstanding

 

 

 

 

used in loss per share calculation

 

 

 

 

during the period (denominator)

11,000,000

11,000,000

11,000,000

11,000,000

 

Dilutive loss per share was not presented, as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share.

XML 14 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 15 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization - Bioethics, Ltd. (“the Company”) was organized under the laws of the State of Nevada on July 26, 1990. The Company has not commenced planned principal operations and is considered a development stage company as defined in ASC Topic No. 915. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of, and at the complete discretion of, the Company’s officers and directors.  The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.

 

Condensed Financial Statements - The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2013 and 2012 and for the periods then ended have been made.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2012 audited financial statements.  The results of operations for the periods ended September 30, 2013 and 2012 are not necessarily indicative of the operating results for the full year.

ZIP 16 0001078782-13-002187-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001078782-13-002187-xbrl.zip M4$L#!!0````(`(-Z;$.%>F.-PQP``'%-`0`1`!P`8F]T:"TR,#$S,#DS,"YX M;6Q55`D``W:-@E)VC8)2=7@+``$$)0X```0Y`0``[%U9<^,XDG[>C=C_@(GI M:5=%6#(I6Y==51/R43V>K;+=)5?O]M,&1$(6NBF"P\,NS:_?3("42)JB+NHT M>Z*G90E$)O)&DL3WX>\_AA9Y9J['A?WQ2*]J1X39AC"Y_?3QB'NBTFK5VQ7] MZ.^?_NL_/_RE4B%W3%Q9U`T\4B'\,[<8Z0;<9]$*'7&%_6IUY,7A#\`&;U6T?3*J1Y= M8G'[SQR6\.<>]<8L!;X[=73[!'Z-!O[P>&+@RVDT3#_YWZ]?NL:`#6DEO>(^ MMQ)7];A@_H`;7M400^3^5&N?:M%HDZ4D[C&C^B2>3^"'C*7B$+Z`^'^\DDVX M"+W=;I_(7Z.A8$IG-;V9-[D:<01V\Q\?\-)S3XK@&^L3.=4Y*O3CD<>'CH4L MR.\&+NM_/.H)?U")%E_]X9E'Y$3.$ZKU_(IZ@XYMXG]N_A7P9VHQV_'I'`YNKO[]WKHT_U M6OO#R4(DBF:JEF;IK*[55^&IXWG,]ZX"UX61JPDD,=6R1&8LX=JW9 M;'PXR9UT5;*OECDWT4@0U^R96<(9@GUV??K$;C"\.2[WV#7K&5T&]5L5]IN9X7`:J6)9JZV?,?FCUPG\ M@7#YOYFYB*S4M4>?:G5-TZ8ECC2!8ABIK9>-6\\+EI.%S*#Y3*C)5V<@2P8% MD;\/?&QF8*-K34*(42B(E27%,8V1;Y!K[""_*/Q]QCXSFF.)B6OKF?A:/]5T M3?^_J!.V#@HU1:&V-@IM36O6&DNNX1=F,Y=:D%@ZYI#;W/-=ZO-G=O/#8;:7 M&Y`SU7U6/XM5##-F+XZ3#/MHM.JUC7.2;U#Z:;O9V`)/>2:H-[6:MGF>,RJ)*TX8\K52&98:R5IK@63S#?+2LHN M"R>>9W^5E`$633S7T"II2YM%/6KD+1L>*WI-CRTV-=WRI+(L"I)]HW!2,RSI M]+2Y#IJY!@2%;JUXFC/L)KNKG!DE*;?1CN[M+K78??_!%6!DN)N[9'WALH[C M6-S`5J>RN4?Z8XDRJU)OUN.)=QFBZV8[RTB;K1UG>U;H;)XFRHQ=7$!^^&W7 M:SN^@!FNF&H,KKZ"L/4^_CGTZDNH0OH\M\,_:P>4/W-A3.3OEC;"Q-P[JPUQ M,^I;(R?.8UE$7[NF+_*AB29W1.3 M+4MF=C8N@,QBV;,0@HMDNR((+I:=IE.\H:X-&P\O:E%?4H\;"UE*NB4^H9HY M]ZK4:UND/MVN-LS&-&M;A0VH6"!\%.M:DSF7(K6(4ZU&:C%WFD(+7,QE%.^< MJO_>VJD'C@K)1S.I%,E3G@;:[>9VN)JW];PJ3ZGGIR"(+J_`=(MB-JV"F9>3GZ[F'Q-.ZY=0R?/\]\]&BQ7N;\ M--?":G[<;&BUTUUA=;$^:;&\WMK/8#4%68`VD\L,$+\DE MC#<8,[W/KACBK79\)>"^'[OM7(BB9U(IDJ)9\BG%YOJZ`I,M[ M@<_,\#G!PI7WFD1AW"RAMO5QDZNPAGH>2D?SDUP+IPOH<;NR7JF#K MSX69KI]7N>V:J'D7(;HF;O.,`)AM[A*SN78PQVM[.;RJ1^KA(O^2/7$;^S[W M?35^>6VKIX-SIEZ-=)[J&NU6>WVD9Y6B\].]L^YURL2-/3KD1U M;L$6276!9F(65;3E;N`X%L,78JB%+\6;`3X!<"=L-/+)5M4V"ZV_PM"T"O$- MK&"&3G=_!?.DAY57$!E9ES_9O,\-:OMAJQK&/@B+&S#R$7BZM'!3GF,DGWZV M_(N_5"KLZ4>E\O.3?X%_.\3S1Q;[^#-UA'A# M'\@0B]I/'W_^5R#\BYN[RO>N^HA#[NX?;XA.*J3[_>O7SK??R?UGTKW]Y>[V M\^U5Y^Z1=*ZN[K_?/=[>_4(>[K_<7MW>=''6$YPV(G$R)G;BX")Y.3`H;1+NH5UZL$]Q81@%IQJ_)PAZP%<5C7!RBA[7 MYS@;MTFG>T4>A<,-JI*W7DYPDU^8+8$!NAH#",P,IP=:Z+USBX)O:R!=Z M#$[KP-X8W(=:L$9'WJ^3V_!>X`%ASX.+;3^`?$E>8)(!&=(1Z3$,\80^4V[) MP?[`%<'30,H/%NL)&Y:-SD<-'P5[+!=.?3D`5VK$F-/Z.(X(.<`U"M7G0W8LM>1`0B(XS.0H&MM4LR:_ M\0=PO5JFN@"$A-/U`Y0#>>$6-H\<&$L"1X2_J7@%JW89;#U<&>/&)A4QA[0$ M?.'"*`NL"WCKTW`YK]R@4/?<#<^_$N!Q-NS,R>>QO*2[*6E5R/+!`&V`&J'C MH&5/-.)-*`SH,U@V8S;:!G@"<-(;)53TPOV!"'Q"`Y/[57*KU`M>9RLS!<.P MP45Q.K`SL`1JHJC4].^4BX#?6P$XGK#!I6SA#J59&(&+;P7'+WA/;(;O<5-W MI!Q6V6N?P*Y,W158YA*B^PE'&E(HL!693T+0'!#$RXRQQ8=P^L[50[ M)GBDCAR$9P7)#Q@-0H>%;07:/<@%K!J$,I'3D)ILOXUSEDTRUZ?@X=SNHZ9D M-%+2$3Z$#!6E+.')$*B4";H)52QC0Z:EC>T+!J!=NB8V\J5YR;]5Q1(E"0OF M?E)OT<#D\#NJ;AQXOD,I!7])3Y%J[\B#L&A,3<;8LT"I8LA]N"`>(F]]3#M> M\/0$)1:FAX&*D1Z+79JY$`B"+J.2%QCY1V`;4D1R(4D+C5V$`D3A2:."$"\2 M`IL2Z*_!%Y2YZL>AE:(33F$LG0"RO2)MX\J\+&5YJB MB"ZB.ZECNA&E?@!!8<2H.\UK8B_0SU7$SGB)'UO;UV,3+:KTG'_UW\L4O#L8;.;/A'@_CTAUKE`!5S!!R>H4*]/CT$G!="<^ MROUQ64A5_HBG.Z[>W-:/-4W#?XDG7S-&,^:$-V%(WQ5#2=FCEO0B>0&A0S1[5:_^)+D@[\"1?L(3`]!I M%3_OMY"!YA`_R/XKE:)O94M5VPFQGFD)N9XEY)H,HCR\X8PSA1PD))]W^,>4 M0)1Z87I\6M3HT:6V1Z6E>OL7P$[!][[=?.D\WER3A\ZWQ]_)X[?.7;=S]7A[ M?[?4]GV/H]G7<4TL70"JB=4W]^H,'6G;-FQ$"=BB/Y@C@2<]T>1FN/$;R5V> M$6N7LQ M<%WQ`@;P4ZTN$Y/,851EKFPE.X&+>@2#.*@/&GP;^N6K)%-(*6KJ'J+9= MV#_"P^0*[?$;+%C'GN"C_F9N`07ZTU"=BK!PQX''?9@L3W'I)N8(4W>S6HL+0HTTR7-\T;YP,EBKZ6<9K(7, M](3OB^'Y7_L:_B_ZUF)]?_Q=N/AH*"CFHD>-/Y\@1MLFKD:XYSZ6?)C?;7\\ M7DY2KY[!RI4<](96K=>=R0A7KDP-B2\S8@/6D^9,79)F#0<"7RGQK!;WY"?? M7%#8>KL6V8U`@XI&UW9$!6>GU>9&53#-*:>%`C5F9D"?$8'@AY"]VHV9LH;: MT!0O:(%$A_+,$Q8WUROXIEYMOX&4%=-BQB?9LBLT->RJKENEJC6]]@9477L+ MJ?^-N&WM36AR#J\LRZ&W50YM1-8;KX#>M*@W6H"\84EO./^_94GOH9S+1+I] M#97CS.7F?>].5;YF-#RQRE=FXS,8')^D]E'.9C;>OH=G9F([A M0-3C8/A459F"BVXYR2OS.TYRR%N+:UMLW9-Z;1[]ET7>/A1YJ4J][`#MG!\? MWMYV[VNKPU/)WE<[!ZB20U9(61SL0W'P/Y(_/%#YF;EXB+(=R#=^1+\L%O;1 MZ_93)^6C'64-\$:-OZP!RAI@RS5`=.A.>-AJX..)0TB\+`'VT>GV4R=EOV#' M5%+6"KNGDD-62%DK[$.M$)WZE3SKBQC4,@)+ONI1%@W[Z'W[J9.R:-@QE91% MP^ZIY)`54A8-^U`TF!-0"H4H1=Z9S!9#/+VW?-IT/_QPMI;U,1S2FU#HGM<> MI3X/JW`I]7E(54^QVHQ52>JCA*J)_C+Y\Y2TOQ1@Q%:Q**ZY%4C`R51_XH5& MZ`02*U8B%WDI.`>$O(H`"!"-&&Q?8DNKVR((5(G`M1$DYG@F=53_BP@LD]!^ MGQD3N.;`'X--F,A8"!0QX6LVV.74D_.3^)9!SP.6@9\;Q)TN#,I]W>?K-TB( M9%K7+DCW^V7WYM?O-W>/Y.8W^/]#@8.;XZS].*8(`[L+$$%'8G\HK<*7$A5B MC`'1HY:$M?`&C/EX0'\23#S\8@KTQ(L"R)"`B1*\C?G,'4J\=(D[&X*YQO$O M0OJ^B'!]%T$W7AYG8JI=)ZS_CB+"^'W_?@(WL@&S7P4^+@8LNA+:WR47S!]P MPSLF7WRS2MY%P,#-BPRTX-;%^Q3D_6E:7*;=+I7Y%$XW"!WHDK:>CW)27)M$AE<8M$`A6<&4K*8 MC.)0._@<^9*@%3"M(WPF$79@C3%`ES'0#)J>Q+%6F$(*XUY"L-!GRBUURD+, M^V"QGD*-`?510V(E'BNDKDENL%@(DNVR,$432(VJ-@Q.+?*/`9N4QU08BVU`]0#@HZQV0.C"6!(^Q4 MI'$Q>;IAK$GC+,$E`H,,C++`NB1L^[:`(R=QYG4$20282^IQ[[X_09O>\?AR M-<8F_SS62G<2_RL9)\_/._728%^]40I^R1\@CI7$*J\J)"K$4.)V6#!-L*B. M9=T5!T=ZIQPQPDX2MC4*,>;!K!"1BTNTRO$%[V.@53(L**_H4^Y:HY3U@KRY M`GS.AD9'"S:H-R!]2T#(I-F`>F-8=/B0!E.'SW8(R#J1TY":BZ34_2MSKA1$ M%2@-`=_H&!JM+X2/,(-182$#K5*FA)"7*I81*-/2XF!R:)>N*>NB0L'D8FHR MQIX%2A5#[L,%"40UB9SF!4]/S!OO#11*U^32S(5`J'49C4#Q_@CL&!CYU$H. M!:@P&F7AALB\,8%-22?7X`O*7/7CT$K1":,-AC>F//9-+ M;9L@;KE_"_-&2`(T&-&-*/4#"`HC1MVBO6;>G/$J*21W9,:`F8$%.26]@[M6 M.\'+D0*SO[*H5]A^+5H-*%_^"XZJ56MU;F5RBC_UY$_[P;7UN1 M=?HI@VQ19]Z,VRDGGA?_ZL!TUWH3JJL=GNIJ2^:;U M46;]K6?]7&RG0_*?K=_V+L2A5L5J.C"-;O5F^/84&L->.BB%;OD6^?84&L=2 M.B2-;O7&^A;5&8-&*FN>G:MY#GB74/8W=E(G97]CQU12]C=V325E?Z/,]6O( M]3.0BP[)@\KLG_U_2'"&1UWH/+GKD(/&O4"?R!<#ELTB\# M_[O-/?BD9NOB:P;$9`8'7KV/1[=WGX\2IQA?MK5?3X](8'/UMYKZZ).NR7\^ MG*Q*?.TKN&VWM+JF3U]#D8MX%#ZU'EQA,&9ZGUTQ?!RP+D6URG$=>1XS,Q>1 M^/?NM6)5L3DGA2(Y>BU!R=.9MC13D6W_1JV`+20,SXRN/?JD535-5PPD)ER< M3,8*TX3.\@C)K\*W=:Y@7I?W`G6T>@[1&_WTM:(;M6:SH4A-G30)G\/\6QOA M3/`0CDZ$:/(H8M89SH%'GAMY#/V>Q5"EWJRW8E@;BY%;'ZO_7]VU]30*1.%G M_X5O^X3,3`NUAMVD]I)MW+1:S6Y\9-M122@T7*S^^YT+UV$*!46Z+Z9"SW?. M-W,NPX$R2&+JX/($317>`R_:#`<]#9V@T0CTJ=%(;O100Y]D=/P@V(@_![9@ MCX&1O,$2\#*]B5S;>Y,LGY2J1BK;,A;]/\8>].`3M_J`"W^FU31/K\BJV7J- MU@S.$ MVSK%Z#9DA8\K+\%,]%Z[GN?N\896_U$FY$O++ID!6*2-M&1A<0CU@VHAT(IJ M6]8ZA?`.%:B"MJDB,)",<.MJ>[(1AC74-O3CHDM%GGP!=%##G1NK%UWK2]6+ M/O;%W$5?^V+UHL]]BOJELV!;--5/8W*=$=Z'U$G35UOJI'FK/6[2?-6>.FF> M:F\H)1=8$.CZH%+A!EM7$W<=TEV]'MYWN'2K*0B4.T,510HXM^PVS=393.B. MH66`].WB"A@J/9"'S2$D^"-R:D-/SVRS?+/%)S).F$/FA!*HJ1-8P?L*/UL^ M[1P&"W-;;NGU?#E]^#D?WY__>IAP9!F&H&!,]'JF/7^8X584B)0>Y/B'$$0*Z;568;U:$0(00E2Z M/CY.BV#0S++)&I48^NQZY2-Z3W<+)`N*%=ZY'MN=+.K%937GX$3N?(@2>;H' M8%B^C?`C]G.\I`B"FM^N'3J!Z7%;RO$7;A9>D!1P_V#;OG'_W%SY>7SR[K^IX?I,/XU2, M8ZH94(/?S(X4$%_W`A9]/"5"A78@TZ/\6SB*T&S:Q&G4$@4IJ*%&%`MTX\CL M@J?ET*@..`,(23XBTM&QXQGP>M>Y_=$,-+&_\]%'<2FH;_UC9Z,O1LF@Q2CA MG;3.6:(C6*+F+&DS"Z;-K%.@6YGZ/D)W",``Z:>1Z>%P".CL(KTM'^9WN;K, M-#%'T"C3Q+?/.F9PJ0"M(0.A67P*\=5O,[[R;>>NZ;)IJZ!+N$:5L,E*BG<5 M.J_E),*:U7+>A.G8?C)%>L.55-PBZY@!H'[6;`;BKEOW@QH M6X*9'[WY#HW]/`/_F-C0XW_9^)4)"_+&FTY0FQ#6KU=H-P"``!1$0``%0`<`&)O M=&@M,C`Q,S`Y,S!?8V%L+GAM;%54"0`#=HV"4G:-@E)U>`L``00E#@``!#D! M``#56-]OVC`0?FZE_@\>?5%&[O.]=>STZLO&*,QB#ZG,E$((_:=<4"3A&G(?:"+>KMQV4086P/.XN>. M_?&H`F1"Q:I;"[6>=PA9+!;UI2=Y7<@9:38:+9(#:V>G)R)6VY]J8(" MT2GCI3`>$Z!#YJNZ+R+CR6TUVJU&P<"ZW+,6'TRR:KCM=INDJT6T<1?H-WC1 M^P5Y77R'9AOHO%78J'KR*JL4'.YABNSS\?YFA^R)A1(6R*?'<>]Q3'S:%;4RR:<\CG0@G3;LT3.L2Y7RO% M^2YNR3_V/N5^PM/V&)EQ*2`L-<0!!'E(2_N_IF=I9#RX\(NQ'6Y[5DBGF*U3 MU'!*E9?JDB@\HW1NPS<)<*WR&5N7)FZX69.>9]-//:5`J]PSIQ[PKO-ND1R2 M6C^1$F*]D6&.*1(M:-F39MXXA1CW&F&6S916N`A]KSOB\2 M4^D[NJ(>ARV;?SWXT,U57?;2B5"1Z7&WU$VL08+2.^E3`?X<^E1ENEZ?YI'H M,Q8:\I:Z!U-8".ZH3%/E5"DV91!L%FT?#Y]#R;UJLE[>UI'(6TC8W$X3+?SG M4'!#4=E;2J^VG^_KS0Z?SG;FQ]1M&XM?[+U2AL=]M._<35OZY[-(LPZUS^%^ M1=:],]H/'*3TA:TM#:I;T)P1S_Y_=GXV.)T_-UFBB_8481P6>'O4[W4($X(C'"-V>' MB!+UY.1XH/8.SS]_V#_]J*J*`XF1A-F**JJ"QBB!"E@A!DL-Y;@SZ)X<*:J: M=T@0_C7,?V8AA0I/A>G9P8*QY5#3;F]O.^M9EG1(=J,==;M]K0P\^+"_MU<$ M#]<4;72X[9?A/>W'Q`;1`J:ABC!E(8[N.E(TI$6[3:*0Y>/:G5*IC@- M!@.M>%J-YG(QNP^OJA]K_QX^B$9/V+DGS&=U[]^TAEF4D01Z<*[<_0T\:SL? MPDR+4:K=Q6AADAPHA=DA^[.$9P<4I,5(4YUSW3\*].W#-U^+:0/DKP/ MP/6FY.(&ONZ;$YX*N&-W:GJZ;[F.1-(U^F\&>;>?5^,[-W1P-;;=[Z^#MR+_ M'N@^;D>HB"$:)82N,@B"R43WKMTQL"X=:\Q?$N;1F6^6+* MS\[35G$3\"6'NZ%/+9]O1[YK?!&GNZ'6.L.Z[')(>:;-WX01W\7]:]_3':`; M0AMK`^76"39Q(H?FI<;$T%O MN)-ID,]M=8<901:BY,7+^$G-EH`V]2#$+EPB%B:`D>B7GX68AE$^&"J*;X=L M6P2;VQ""6#E[\J.`[UD707YT$H6X0[8MB,UMB$"L.7X*,MRAVA+"!BY.BP]` M]Y_.>,M?4$L#!!0````(`(-Z;$-F^^X801<```H)`0`5`!P`8F]T:"TR,#$S M,#DS,%]L86(N>&UL550)``-VC8)2=HV"4G5X"P`!!"4.```$.0$``.U=;9/; M-I+^G*W:_X#S7MTX5=:\V)6KV$EV2Z/1.*J,I8FDR<:?4A`)23A3I,*7\ MW7\_-$A*%-\`$A"%J=H/B6T*Z&XT'H+=C4;CQW\\;1ST2/R`>NY/9U?GEV>( MN)9G4W?UTQD-O-[WWW_WOG=U]H^___4O/_Y'KX?&Q!LXV(\"U$/TECH$S2(: MDI0&^N[\_>7W;U&O!QTFFS'CSJ7;WMO;LZ?PKLC*!+ZARP65"/A&MJ M!>>6MV&4KMY=OG]WF>D`)!OJHM`ET<;5^_?O+_BOV=:,G!WNFF>I?W<1_YAK M36O$V6F8S>HW/_J>0Z9DB3C/#^'SEOST*J";K4->)<_6/EF6DW-\_P+Z7[AD MA4-B@TK?@TJO_AM4^K?D\1U>$.<5@I8/TU&E9.\/:,6=+KJ2\9[XU+.';CMA M<[T[EGH68C]4D#O3OS/)YVR)(:UDSO3L3EHOQ$X[:?<]8VGC910>W+&_'0A- MGD+BVL1.Q08Z->\Q9\-7"B"<4O:L+,TS!]9-SS_+:N)LX87K7KJ.\7&R)>^/ MOF7Y$;%';DA\$H03=^R%)$A[)$5`UH?",):>I%OD1P]]L$,DI)HXF+./$?+_:"G%9TV[.B#7%#_H73 M-82^;R'/MXF?F`+9$6'?2A^POPI$3%I<6![[:&S#7JIHWGWI>YM:5*1\/:'" M+O3`>#J\Z\^'-_?]Z?SS?-H?S_J#^6C"_E@$H8^ML`30PBY*T)852`7D"0_$ MF:`LEP\F8416%5FT-)L<&=QDS:@E#A9\&%'06V&\!?/N[05QPB!]`@A[V[N\ M2NS$OR6/_QB3<("#];WO/5*V:%\_/P2`Z5OJ,N.*F=Q]*Z2/-*2%);0%@=;X M:R^L"AH9-P3L4,H/+9[1CA?:,S,%F^W5E")5=5*[P^W`VVP\=Q9ZUI?9&C/L M]*-P[?GT7\2N`&I=#V5D2HBC`L68/.+TWZ"8`]JS,`V`$MK((TYZ=KJ#&/O` M>Y$;!O?X&2\<,HA\GUDW%>BJ:*P,K'HA%"U*3AEM8]*F@:A^Y'G\R.B_*70" M8IVOO,<+F]`8->PO>;"P1W\,W9"&SP/&S\?.B/D^3[^0Y]R<5K=K#1$A:Q5T MQ(110AEQTHC1-@4EPL&G`)%4?'M+?19MF9/.'1\'HG]VY)#)U98(CMA$#8M1N;8B;J0N0S M'ULG7;M..O2:=:OTO2W=V17,JK8(L8-;II6!Q]8DNHA"8@_PEK)15-@7@D[* M=H:<4$HV;$P*62EUAGA3H-E,"WG;H\G<=`>SR9;X&-`_?-H2-V`6=7GH2-Q> M&5Q"490LE=_OA^/9T)P0D?2H\SB2G('N(#0EC\2-*D,_NY^5`9)GI!9$_&TX M?AB:AH;\$/.37Z[,[N::N]YS'[L!`QQ;FIDG!1[4FH34PLX-#2S'"R)?N(PT MIZ.,GM:BJ\#L@(4?`E-PZ*<$@H!P093TQW*[BA>4*=N/R3;0AD_ M)>Q4P,*W\5&&J&E0*1EO'A>5^FT?P4D,=;[4#3+>2J["+4B1&5B"EA:-_ M/YKW[]!L/AG\@@:3\7PZNGZ`/4EC#.DFJL@&!9I-CDKD;Q&0/R.V2@V9[18& M5S6`J6ZK&+,3B*`4D'NXG@U_?8#/"]C4\YE)P!"._#!,)*7][KXC[+/F$QR0 M&Q+_.7)S&Q@57Q=Q/^5OCK1H*M!*F:#7=L+F6T1=A`W?DY+63?ZKU7#>.LS_ M@*2E1(8I<7@Z)?;AZSIPO$&_-IS M&.I,@V8+S12R/MK.9/M/Z+7G^]Y78D/HM)_1;LD7M+*IT@=4)(`*>E+:"(@C M+(N>KL47[4'=>S[\`KM.S.]'%O;]9[[?M($%#.$@_66!')@M_2N?\(V<`-D10=AQD!]CD'T,.`@9 M#QPBNOLX(+P,B8\\EZ!G@GV@M"#/GFMS85S/WS!GQTMCJLAZME@?NF3LW!7Q MSTUY@66F,6O+R+T'"M[0Y-,]\P/&'^\FL]G]<#K[N3\=UN6="CJH>4)2PBCY M02D'!"P0XX%B)F:Y05)Z.'""&LS*R=--=SL?;=--RP@<*]VT1E@MZ::O@29+)IL(I/:6WMA,NB34(-D4:$#B"_R825FGY7+-_L6\S.&]! M0-C7&])0G'V0SIAEM+U^Q,Z+Q(S<-R,93@K[P^8B[7R_.I\Y<-6&K*52]EJR%7F=%%*V!1H M",9=3%.NT?>QX-!G?K<-OO>M@U:G>\: MM7:YH_UG1&V&NWTNQT>$EIYOC!_43".'^^K-YNDT*?7978QJ[Z>\N=8T^C)!E#(.$]H( MYC&)GANZ3RI20UT&??6$G#+@DY9Y2`1C7JITJ*>DZQ&"/-4"'F>?GI?RH`E3 MT_#71#WBZ(YH`CM%00A)3LK+X&-A)2!9UE\7%COK/MU%%8 M&5M,FIY,R&S2MV0F9&D7;9F0=0+I.)C&F:`L%U.@U$0358F0XKDQ<1=0L*2U M(-3AKJ!V[^+6\;XFYM^+6/K:JZK]'N&IL9V>XQ(@M]!,VQDZO06Y^%DZXX!5 M-=:J0W6G!D6FNLUOV(FJ_-)",YUUB0X8:RA&%`#1']!_GE]>7D&*%GH$!F_0 MV^_>7%Y>PG\HB`L5X5TIGS?HZBK_*PT"<"5@V]B+0BCJ"J5^34-9WPQO1X/1_%OC%C"Q1DH/8DK,3X?UL7B^AZ`LUD$;]6I892S53\0E M!%%,WC2LE`ZZ4/^J6M''VC6\2?*&;VE@8>Y+/.*EKJ;23*&"O@HJ4 M-(II(R"..'53L"&A@.Q.H]0$M`\;I!D,9;9-\7>E@$`I*Z6H.O%C2R2V7W0E MYK>64Y2-?XLMDJ;>>TSTD*?(<]DAV][*&&>P^Q2/[0>T(BYSE1R'I]TCRFPL MN(G@D:2Y^TM,?;3!_A<2)L1VG8W*E"_5:S;F48,UA:+B@\'D80S9U/>3.V91 MU.;#US16*RXN%$(ICV)'':7D39IW\>`/:G-+3D%WQM(-\T0=;PMO]BS$*S*$ M/86M3V&?84DM&O8M]MY'_,!+O+^:[U%A86D@K&R6Z1NZ,7*2>AOUCD9)0YW5-X[F/\XGI?W1G!@><2 M>P0AROR99'%[#;G2`E$T9$T#A]X78(%2'BAF8@J,I+51S*66FAF%2UJ(19@/ M97.'(W[WLO5FRLH["[NH7=(B*9#2GE#"(W8.8R8'15V-^9`UTWHT%_/&\4%VE(0*TN5BMAU8IE<8YHE1_?T#@)GM``&0P#7UMU%-([VD]H2?/KBVY`:5= M=FT=H0ZO>#QF=FW9-3K&F&WJJFI_W>.IS;A)N"9^;#*PUU#V9I/Z3NK7FT@) MI7309?[S<(I&X\'DTQ"]3NJ\?VL:(.7T4+CUI,'L'#?N>Q\M'&JQ90#GD53> M1D-\MX2EAIAN3!5QLJ:`I';,QMDR6+&\%-LIKRB5 MK%7`P2;'AG?+1LMX88I5;10^('Y$Y*?M.0+QR_J-*8PMZ`IM,IF6L[P?,`UVOD+J%D<\W% M*TU[JY];:2:FTO9!]J+7S+5:D)^[\TY1AKEQ[FA#917.M[295+5"1?WPFJRH M"Z_&9!G'<$JVK:I:*IS*5NP)R*>/?^ M'&*63F3#NP6N)_I"79N_9[O;1WBA^35^)#QQ-$F=1Q9;.AD"V5`9,8OWR/$_ M1WTG\!BWA'ZP]ORPQWILWJ`U7:V=9^3P6ERL"5Q-')>[Y]S@``(@%?D$VY0U M9&_<(_%#"ME=H8?B#)TX[Y^SYI<_`W/&T(7S*4Q4GL+/;!WP`3E5]NP9;=EL M0JHA4P)=N71)+$+.@"!OH\"D9XTX. M_A>R#XKRR6`];1HP[3#]K7POVO*F[!$DC%`7(T MM;`@W0FN9)@L,^=2*[ZJXGY:JV/5BJ:O3-;!>1B:\#0%:(WU4E45TZ*`WU0)'GNZ:D!UCYBZ\'),W!FS$IFIY,/2`F_! M-6&^'NDS)Y#9I\SHS>0%52"P'2UE7"H-03FH=CV\G4R'Z58@PZTYQS2U*"B/ M8PV3?)+3:GW7+E;LJ`"RL)O.DVRU@JF?:\MPXJY>EE=:G(6SA(0A?O;0N&UL M6675G(*3F,83U6D1&=.E;?76;=&:N//`OM^09CV;#9G[J+CU,%]SYYI%X4 M.,_]N"P<PT"4UKF8?UHL+RF=M]V)D-;8X_YZ M%*(HEN(@_*4M^M^1+D1;!,?62>;!?$GRUCZR;X\9-W-9LUH*'^16HFLLA:D#!&..2*7L\Q6?XI?A4PYS3B2 M1]TXQ+6_+:)JZWH2[,MG%F>BN]YS^$"ECI-*%_'U;L M/V+J@+\[]S+O:^)HU+T63:GH2.5O([92B`30G>S[\/U%OOV]2_M">!LY<)FAL(^);Z+$GV;X^#DY]B&?&-L4BX3P.D^Q[-B] MP%,L$JJ2/,4B/=$G6M!EEFO-B[$.L(V'6,WB#8A9H\B)JOE?JHZ;^NV"&3ED+O@)>Q]AZ..9FPPO< M7)#?3M"]@=#L+%R#Q4FRDX;3H)+C+R5=`Z%U\82TWN0#L80>Q%0#PH4^K-F(."4KHY*%0D M!Z_V6/\X&8T_#B;CP7`ZKJF#5=I,">%UC%7`S>FBA+`QGJ-HQ-DY%^O:Q(B& M2A/$IIY0?))V6A2],P6![-;6/6ISB5I?TAF^9>UVR;37>[%(B M@E+.9^YNEYB\Z;>[E"BA^GZ7RHE0N``C+CR=5N::XA`N?^^[;K0I^<+5M5:[ M`D,LAE)R?+Z\-C``A"#.0I=%IVD4PB-T[4?3]>=<0B,'UWO(XDL!\/%)NW@Q MAIWT"!9C"!>FAZCK;H"1[ZSV.C064NGM2`X?`CL&*K1CB/BV&P"+\S0*6(TU M=("SEO-XDACR/?8G_HQ?!\7O/DI%%(>2*WOJC"B+Q-,76&:-#O[F.>S%P/[S+768-UT9$,RWTQ`#K&"M(>RWHXQBTJ;`1SCV M8F2O5N_']AQB\W/HVC<,HS5>PV$[+1Y#*6LMWD+B)C#2"&B;A(W:P9=Y"36* M[[($S"(@?T9,G.$C/T8I*(54W5Y#F1>!*$H!XH?KV?#7!SBD`)>ISV>ZJR%I MD;ZV&E)A"*:@7UH%Q6(S4F!22'SOWX_F_3M^-76-HU#:3"U1O8:QDHD5TT6< ML%&AX+H1'Z1#"W7=81G;]!2X,`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`5='6BM;Z MJXHZIH/.8N9'K"A]-^I?C^Y&8[\LW:&^ MK6*&GD`$M72&N&00=1'AY&%S8HO]."G+%*Q(J>$P0TIJ*HY-`%\QP'%+$S!CZPJ2JJKU4Q*=G1W[&_L6?J( M_6^!`\*>_#]02P,$%`````@`@WIL0P,>.?E6#0``";4``!4`'`!B;W1H+3(P M,3,P.3,P7W!R92YX;6Q55`D``W:-@E)VC8)2=7@+``$$)0X```0Y`0``W5W= M=]HX%G^>.6?^![;SD"="TFYWFY[ISG'`M)Q2S((SL_/4(VP!VC$6(]GYV+]^ M)0R);:P/@\%R7IK4N9+O_?UTKZX^_771@J&'?10N M/ET@BML?/KR_:5]?_/JOGW[\Y6_M=FL$<3<`)*:M=@OU40!;TQA%<%='Z_WE MS=6'MZUVFQ<(4/CG1_[/#%#88J\*Z:+A]G)+C$9-%Y>W7U MKK,3?//3CS_\L!'^^$A1IL##NYWX=><_WX93;PE7H(U"&H'0VQ:DZ"/=/!]B M#T3<+O4K6T()_K_V3JS-'[6OW[;?75\^4C^EZ!P%F=?,$(;1$GGTTL,K5M/U MNZN;=U>I`KS*DECL%=FB<7US<]/9_#4MS:KSHV?Q=.WO.\D?<])(HLXSPHS5 M'Q):"0[@!,Y;_.?=9*!A?8>+=I!/OO>P%Z]@&.U^6J%OAQ&*G@;A')/5AK4W MK8U)'Z.G-?STAJ+5.H"[9TL"YY_>S'"T;.\JYWS\K%UWY\6.-8&4B6V>#]F# MS&OA8P1#'_J[%W,+JK>4*[/5)L!>6H&+@+=A3"[2AE_L&\Z:WW?9*ZP9C0CP MHET]`9C!X-.%=K%.6173S8Y"[W*![SL^1!RAM_P7KO[;]M7UUI-^9H^^)Z^? MP`7B;PVC$5C!G,)"L;2":48MDE46$&]7)?MU0^>%L-5O)3IK0%A];6^)`G]7 M>D[PJ@2`.R6PQ(963)DV>,T+@N"BA8D/21*4SX+_SA"755N`>^;/#<,[:UHQ MSF_/C?,8$H29#7X/1#+`LW(-13YG;#$%[\Y%@<54\KE:_0`L"J#/_KUAD.>, M*X;Z[^>".E&[R]0A(!BPSO3Q*WP2AO6\7,.@%QA;3,'[/(%K3"+6)J8,QYB* M':18O)%TB$POYN7FO+S\AH.8@4B21B,F)"_72";VC!4,TZ[.R\'O,`B^AO@A MG$)`<0C]`:4Q)$(N1/*-Y$1HO(";LX^A7Q*//GM2Y"$BR8;Q(318P,391]F) M8LGP4X^+M&RCV<@8+>#C;$/NQ(9Q/`N0UP\PR,]%%LLT#/\"(P6X/X^_?^GL M&3=D#ZJ9:+\;67>]@6OWNLZH9X^F=N_6&EJCKCW]8MON]-`Y=E6U9YM>5RER M3,.>`SK;M)F8MA<`K)/6#8.([I[DF_GV\7>+4AA1P9R[0.@H'SQ6U6VRJ:5Q M7K8F#Y5CS?U18>*))ML/IZ(+Z)+%&O[#_BM&]R!@^E(KZ@)"GM@(X#<0Q/DI MFW)EC:!*T-;2C&DB(6:PQ:R;0_8>?YC@)-1^HWK$TGJXD33"#77CEEP'8,G M,`N@(@(5"]?,B+IQ97Q$8+!QZ<`@9-T2I)$6,P+A1C$C,M@XGQGA".[:SP0& M((+^&)"-E0&@%,T1].5TE:FA41R6@J8!W91V]]0LFHH,/=$V@4K84-/06/Q/ MMCG@<.`WZ[%+'#`]*!]_14^*;$U2P/AL36:L<0$JM5XNG0W(B]7,@KI!94;_ M>T96F)L5;YWM@C6*^(8=^]&#E#ISUFD5`2R7;03*"G.-2[9Z\!X&>,TGXJ<1 M6$";9XEK@BCLP3GR4,02^G@5;U*-7DQ0N,B7$#A)!14W@O`J@30N(.Y#H-U% M-8N](D--SMBLT-?F1EG,^"1";;B"JSH7`"'J(>@&F,8-))PTO54_]:2Q3T2%\;QOT M-QG(&)+-3E!U9BLL:4)TW>RJT^9N*_TJ>=LA85P&7.(D@5:15\F>QK&"NE*QJ6NY]C>6A$R= MOC.V)Y8[<$859F&"^FM,P`0:U>,^$S;-E:K4G5I.W[_10J%FW%XM033OI MBRG&Y3'.&A+`#UW8CVL84F7K$,LW@`>)L<8E*)]AR)0-V!C;\EC]`] MW*HNH$=5JF:2E*TMS982`7.=:1"R'@(.,15%KR+))G%3:*EQ/N2P9(HD&O*= M[9H13EZH"6%.8;9QB?UN.XP\MN6EZO87K<95M.O'W`#V&:"0^[(33D$`G?F8 M8.;H?*[W%LXQ@=9Z';#!R2R`B>$N>!0F:(?5U3A2#X3,N%BYWPTX`/8]W`WEJ@?!^%@(T7CO=Y645FLE^-STL!-"[R,^T]"'W:9P#Q MO;S\8S;./+515#Q#HBAG)L<:S3LWB:*"QSC'3NOW90`S;J&X^%;&Y([A M_)A2M#6F3!5F,EXR>2H'6H6[LP337)TR20;S8H4@@KO MX9&!;X>^$O:TS"L!/&/VB;[!<\01['B]#B!?2@(!U[KM%OS[U;[,=\9/\(A MM^%E*C7TU<.GHZMK#&/'`Z<8-)]TB^?+Y&[F#T>>Q,QQT!_;!>SU+O^=LFSY+:U:1KVF]3)(EE*R@KJP5+4(T1QX( MH^VN"=;XQSA`'FOZ+B/O-A#/;&L6KC%4',9B)E?5!$C1'9\I2'2M\<"UAE/7 MZ7X]/A1D:JO!X3/OKRCA3U4I2_&+Q(RYH)#/Z;Z@I/12[?)U]ND27N27&`K! M,,,C)_;0V)JX?[@3:S2UND==SZ)1*M2E&J\552_Q8&61VJY?>;[2 M_BE]29&^/Y>IH4:/UN4L>Z%+"7#,\._/#DLDNLZH:T]&Q_MTIK8:_#CS_FI\ M-UVEQ%\+Q6J[A);U+#[K6U+`8+ZW$8<>)"'O<02^J5.R1I^4<9&]C%8#`#/\ M;^A,IV-[,OUB3>SC_2]36PW^EWE_-?Z7/[=Z+7%"L:PA)XM5?:-8OD:O4S(@ M.V:LU>$=^;'"L\U@W4[M?]_9(]?^C1_9K6*N*E=C+;-2.1VJFNN=4?A7S"RP M[_EZO\QMQ;*UK85F%5(.487R=+C:'"Y-=KYT\6H=<^WXB>/GG(UOMJT@.&J^J(Y( MJ:E:16%3^399&-4O7%>V]+PBG4_^>RC@V^YOGY)C%)L/8"ISJ0-KJS,PE.8W MDWH="E\S$[.N\VU\QX-H>JZ@!R.`@H,3,FF=9PLO4BTJ6OXK>H4L"5,4,.&6 M.^N>`<2CK8M3IZVV:V2RJ]C*UE+G\J`6;\([\W0@,B['^QVBQ9*%+^N>):(+ M.(I7,TB<^=[G*&04EZNC4027A*?.W'%[;&[OPR3'1FU%M><+W`I%JMJK7?P6 MZ4YM19&JMI&SG`6$3\D7?I(6.";P'N&8!D_;[S6QY.8VCNY"1-EOXE/#1U=7 MZ\9,/8:>]YL?!=O)/^GK8F9,^BRENX3)9=0;#9*L=>_;5F5*-H@K;3!.O@MZ ME]V+OJZ<_7N#(,X95N%97<$2`W_9-@EZ/N1=,*LGEVT0P!*#Z_RB5WKO6]<9 MN9/![1W?*G-L>J"H]GSI@4*1ZM.#-+F:Z4%AD8H<;0(]B.ZW75S2_E3^IBQB MB-O)D-ZYG=K\.K>2"/:I'>E\BEK/YGL*/HL)P0_0YUF. ME9HI*'!3H6CM%]KK(;QS4;'))\^R+<\C,9_X3+!&RPC!>%_)_4$L#!!0````( M`(-Z;$/,/=QUA@<``%,Z```1`!P`8F]T:"TR,#$S,#DS,"YX:DKU.QBYK M4K1$S:A6)A61RFZ>IB`2LE"A``4`??S[!7A8I'AJ/1FYMO1B\^C^NAL?NG$0 MNOWE>1."1\0XIF2@]<][&D#$IP$F#P,-U7S[]_6^W/^HZL!$= MAI!%'.@`CW&(@!MA@3(,<'5^W?MX`71=*7!_C3802!N$WQ!*2+09:&LAMC>& M\?3T=/Z\9.$Y90]&()@A7K;(D$*ZE$(,^UJB5U!XNHS%+WJ]OO&?^ZD;XVN9 M@7;T`O)-Q/4'"+>O2BO(E[%"^D+:Z5_HO;Y^V<]40DS^J#8B?;HTU.LEY$BV M8H@VB(@Q99L16L$H%`/MSPB&>(51D*&M<%@`6V**Q!K[_-RG&V7]LG=]VRXU64IB__KZVHC?Y@,,1!$\C>[*2%YJLEO]<`L)H0(*V=_4K;S? M;C%9T?CFAUL%>9,Q,437>&,PC(_!)*J1$D"-TB)C#BK]WHS/@V(05H M=6A(4@43_%X#"N'RT("D"@K?8RP^#`^-1:KX4?@7=S>%X_/)W<*;./8("8A#?@9P,#CK(IAXE+JTZY2? M>G((^*DG!R%7IEU<:N5U"@9B-)"'`Q]2P'_<&OM0>0L11X%#/L77^UF=:J8B M=5K%Q.FFL\=GA5+Z*./DV_'DW,]D`]F?IX[KSJRY^\6<6V62FJ2:&/IGB:$, M"2@H(+%`#';BIYJ?A6TN1A//&LG./+)LUQJYGNE9]Y;MNP4%KZA@!POH"BA@$".?^,OS-\+<#RF/&'(7]_?F_'=G[$X^ MVY/Q9&C:GCD<.@M;I:<-J9EDUH3E9==DC,%!PDZ*,*?"*W. MT/S@5I6'A?=-HUZOE&W%P>Y$0#4!GQU9=V0G'EISNXJ`PONF'+DN$1"K@E3W MU/YU0]2=:_VZD*7"^DT-[-6#T9Y,4R+T*X:=3!TD^B'GUU"+8E$&EJ7@*!F(TD(<[+:&J>9I;4[E2&[-S=MUQQ6[D2T MR#6Q]/,^2RD6B,%`#NU$4ML@E-\0JAJ`"N^;BMO/I<&GL#UT:O\#EC6=%S*- MC%P7-.?`APSJ1U7WC?.S,K+FY5S`[:S25 MS=('CY:M&KE/\O*F\+W^%F^VE`F0G`Z94C]^TW"P0=WIV>D& M73W2^Q?Z9?_\F0<:()7''&J.1AB'.K!_=D29OU;F^S]U,E\Z>_(&#RBQW^I$ M[GC-P8[DCF$H!Z[J3%>>V^AB+5:L/(1CH%#P[(F^.V12YT+C29[.KNP?;%$7 M'8PW'HI)C*>G@P!<*VEEKDWKN!G5Z5M]:YH=B')< M%G,;U?VZW9&V4-KUCLL*Y.L9Q,$H4MK>&LUB/\:4M7+40?.[A)8/ MQ11WZ`$3-8HZJ\2A)O\KQ1.;2QBJE8#T&"WQMPME0PD2D+UT"\8B0;82#_5M2_P(U8G3>NG%6_! M/&JSU.=?]4>_]NQKT_N^N2>G#Y"\3#B/4!#/'?B,H4=,(QZ^F)%84X;E/.,N M$@N"N;R2"K+)8O=K0WP39CG\9'$O#HL^-ML6O4O81Y[+.0];8^`T*1PVH2PW, M$W!(#:S6^ZXU<(Y\A!_34I7TIT[]KUVO,VM_Z8AN^K[T6JX5!9(U4&UL550%``-VC8)2=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`@WIL0UJ]7:#<`@``41$``!4`&``````` M`0```*2!#AT``&)O=&@M,C`Q,S`Y,S!?8V%L+GAM;%54!0`#=HV"4G5X"P`! M!"4.```$.0$``%!+`0(>`Q0````(`(-Z;$.E"+3*AP,``*H;```5`!@````` M``$```"D@3D@``!B;W1H+3(P,3,P.3,P7V1E9BYX;6Q55`4``W:-@E)U>`L` M`00E#@``!#D!``!02P$"'@,4````"`"#>FQ#9OON&$$7```*"0$`%0`8```` M```!````I($/)```8F]T:"TR,#$S,#DS,%]L86(N>&UL550%``-VC8)2=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`@WIL0P,>.?E6#0``";4``!4`&``` M`````0```*2!GSL``&)O=&@M,C`Q,S`Y,S!?<')E+GAM;%54!0`#=HV"4G5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`(-Z;$/,/=QUA@<``%,Z```1`!@` M``````$```"D@41)``!B;W1H+3(P,3,P.3,P+GAS9%54!0`#=HV"4G5X"P`! @!"4.```$.0$``%!+!08`````!@`&`!H"```540`````` ` end XML 17 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2013
RELATED PARTY TRANSACTIONS:  
RELATED PARTY TRANSACTIONS

NOTE 3 - RELATED PARTY TRANSACTIONS

 

Management Compensation - During the nine months ended September 30, 2013 and 2012, the Company did not pay any compensation to its officers and directors.

 

Office Space - The Company has not had a need to rent office space.  An officer/shareholder of the Company is allowing the Company to use his home as a mailing address, as needed, at no expense to the Company.

 

Notes Payable - In January 2010, the Company borrowed $25,000 from a stockholder of the Company pursuant to an unsecured promissory note.  In May and June 2011, the Company borrowed $5,000 and $20,000 from a stockholder of the Company pursuant to unsecured promissory notes.  In July 2012, the Company borrowed $20,000 from a stockholder of the Company pursuant to an unsecured promissory note.  In May 2013, the Company borrowed $10,000 from a stockholder of the Company pursuant to an unsecured promissory note.  Such notes are due on demand and accrue interest at 6% per annum.  At September 30, 2013 accrued interest on such notes was $10,667.

XML 18 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2013
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 6 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are no additional events to disclose.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN
9 Months Ended
Sep. 30, 2013
GOING CONCERN:  
Going Concern Note

NOTE 4 - GOING CONCERN

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.  However, the Company has incurred losses since its inception and has no on-going operations.  These factors raise substantial doubt about the ability of the Company to continue as a going concern.  In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans, additional sales of its common stock or through a possible business combination.  There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations.  The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

EXCEL 20 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F-64Y93-C,U\X.6(V7S1B-#!?838R-E]B-#8S M8S=D93DY-S0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E5.055$251%1%]#3TY$14Y3141?4U1!5$5-14Y4 M4S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I7;W)K M#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D%#0T]53E1)3D=?4$],24-) M15-?4&]L:6-I97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I3='EL97-H965T($A2968] M,T0B5V]R:W-H965T&-E;"!84"!O3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F-64Y93-C,U\X.6(V7S1B-#!?838R-E]B-#8S M8S=D93DY-S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C5E.64S M8S-?.#EB-E\T8C0P7V$V,C9?8C0V,V,W9&4Y.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!);F9O2!);F9O'0^)SQS<&%N/CPO2!296=I'0^ M)SQS<&%N/CPO'0^)S$P+5$\"!+97D\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^ M)RTM,3(M,S$\'0^)SQS<&%N M/CPO'0^)UEE2!6;VQU;G1A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4@+2!3=&]C:VAO;&1E6%B M;&4@+2!3=&]C:VAO;&1E'0^)SQS<&%N/CPOF5D+"`Q,2PP,#`L,#`P('-H87)E2`H1&5F:6-I="D\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2!/<&5R871I;F<@06-T:79I=&EE M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO"TM/CQP('-T>6QE/3-$)VUAF5D('5N9&5R('1H92!L87=S(&]F('1H92!3=&%T92!O M9B!.979A9&$@;VX@2G5L>2`R-BP@,3DY,"X@5&AE($-O;7!A;GD@:&%S(&YO M="!C;VUM96YC960@<&QA;FYE9"!P2!P2!B96-O;64@879A:6QA8FQE('1H2!H87,L(&%T('1H92!P2!T;R!P2!T:&4@9FEN86YC:6%L('!O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`Q.3DX+"!T:&4@0V]M<&%N>2!I M7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO6QE/3-$)W1E>'0M86QI M9VXZ:G5S=&EF>3MM87)G:6XZ,&-M(#!C;2`P<'0@,3AP="<^)FYB2!D:60@;F]T('!A>2!A;GD@8V]M M<&5N6QE/3-$)W1E>'0M86QI9VXZ:G5S=&EF>3MM87)G:6XZ M,&-M(#!C;2`P<'0@,3AP="<^)FYB2`R,#$P+"!T:&4@0V]M M<&%N>2!B;W)R;W=E9"`D,C4L,#`P(&9R;VT@82!S=&]C:VAO;&1E2!P=7)S=6%N="!T;R!A;B!U;G-E8W5R960@<')O;6ES2!N;W1E+B9N8G-P.R!);B!-87D@86YD($IU;F4@,C`Q,2P@=&AE($-O;7!A M;GD@8F]R2!P=7)S=6%N="!T;R!U;G-E8W5R960@<')O M;6ES2!N;W1E2`R,#$R+"!T:&4@0V]M<&%N M>2!B;W)R;W=E9"`D,C`L,#`P(&9R;VT@82!S=&]C:VAO;&1E2!P=7)S=6%N="!T;R!A;B!U;G-E8W5R960@<')O;6ES2!N M;W1E+B9N8G-P.R!);B!-87D@,C`Q,RP@=&AE($-O;7!A;GD@8F]R'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE M/3-$)VQI;F4M:&5I9VAT.FYO2!A2!A9&1I=&EO;F%L(&9U;F1S(&YO="!P2!O<&5R871I;VYS('1H6QE/3-$)VUA7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SPA+2UE9W@M+3X\ M<"!S='EL93TS1"=T97AT+6%L:6=N.FIU6QE/3-$)W1E>'0M86QI9VXZ:G5S=&EF>3MM87)G:6XZ,&-M(#!C;2`P M<'0@,3AP="<^/&9O;G0@;&%N9STS1$5.+553/E1H92!F;VQL;W=I;F<@9&%T M82!S:&]W('1H92!A;6]U;G1S('5S960@:6X@8V]M<'5T:6YG(&QO6QE/3-$)W1E>'0M86QI9VXZ:G5S M=&EF>3MM87)G:6XZ,&-M(#!C;2`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`P<'0G/CQB/CQF;VYT(&QA;F<],T1%3BU54SY.3U1%(#8@)B,Q M-3`[(%-50E-%455%3E0@159%3E13/"]F;VYT/CPO8CX\+W`^(#QP('-T>6QE M/3-$)W1E>'0M86QI9VXZ:G5S=&EF>3MM87)G:6XZ,&-M(#!C;2`P<'0@,3AP M="<^)FYB2!H87,@979A;'5A=&5D('-U8G-E<75E;G0@979E;G1S(&9R M;VT@=&AE(&)A;&%N8V4@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F-64Y93-C,U\X.6(V7S1B-#!?838R-E]B-#8S8S=D93DY-S0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C5E.64S8S-?.#EB-E\T M8C0P7V$V,C9?8C0V,V,W9&4Y.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SPA M+2UE9W@M+3X\<"!S='EL93TS1"=T97AT+6%L:6=N.FIUF5D('5N9&5R('1H92!L87=S(&]F('1H92!3=&%T92!O9B!.979A9&$@ M;VX@2G5L>2`R-BP@,3DY,"X@5&AE($-O;7!A;GD@:&%S(&YO="!C;VUM96YC M960@<&QA;FYE9"!P2!P2!B96-O;64@879A:6QA8FQE('1H2!H87,L(&%T('1H92!P6EN9R!F:6YA;F-I86P@6QE/3-$)W1E>'0M86QI9VXZ:G5S=&EF>3MM87)G:6XZ,&-M(#!C M;2`P<'0@,3AP="<^)FYB2!I;F-L=61E9"!I;B!F:6YA;F-I86P@2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T M871E6QE/3-$)W1E>'0M86QI M9VXZ:G5S=&EF>3MM87)G:6XZ,&-M(#!C;2`P<'0G/B9N8G-P.SPO<#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SPA+2UE9W@M+3X\<"!S='EL93TS1"=M87)G:6XZ,&EN(#!I;B`P<'0@ M,"XR-6EN.W1E>'0M86QI9VXZ:G5S=&EF>2<^5&AE(&9O;&QO=VEN9R!D871A M('-H;W<@=&AE(&%M;W5N=',@=7-E9"!I;B!C;VUP=71I;F<@;&]S'0M86QI9VXZ:G5S=&EF>2<^)FYB6QE/3-$=VED=&@Z-#0X M+C9P=#MB;W)D97(M8V]L;&%P6QE/3-$)V)O6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)V)O'0M86QI M9VXZ8V5N=&5R)SY&;W(@=&AE($YI;F4@/"]P/B`\<"!A;&EG;CTS1&-E;G1E M6QE/3-$)V)O6QE/3-$)VUA6QE/3-$)V)O M'0M86QI9VXZ8V5N=&5R)SXF;F)S<#LF;F)S<#LF;F)S<#L@ M,C`Q,CPO<#X\+W1D/B`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!I'0^ M)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2`S,2P@,C`Q,3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C M:&5M87,M;6EC'1087)T7V8U93EE,V,S7S@Y8C9?-&(T,%]A-C(V7V(T-C-C-V1E.3DW-"TM "#0H` ` end XML 21 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 17 73 1 false 0 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.bioethics.com/20130930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - UNAUDITED CONDENSED BALANCE SHEETS Sheet http://www.bioethics.com/20130930/role/idr_UNAUDITEDCONDENSEDBALANCESHEETS UNAUDITED CONDENSED BALANCE SHEETS false false R3.htm 000030 - Statement - UNAUDITED CONDENSED BALANCE SHEETS PARENTHETICALS Sheet http://www.bioethics.com/20130930/role/idr_UNAUDITEDCONDENSEDBALANCESHEETSPARENTHETICALS UNAUDITED CONDENSED BALANCE SHEETS PARENTHETICALS false false R4.htm 000040 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.bioethics.com/20130930/role/idr_UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS UNAUDITED CONDENSED STATEMENTS OF OPERATIONS false false R5.htm 000050 - Statement - UNAUDITED CONDENSED STATEMENTS of CASH FLOWS Sheet http://www.bioethics.com/20130930/role/idr_UNAUDITEDCONDENSEDSTATEMENTSOfCASHFLOWS UNAUDITED CONDENSED STATEMENTS of CASH FLOWS false false R6.htm 000060 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.bioethics.com/20130930/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 000070 - Disclosure - CAPITAL STOCK Sheet http://www.bioethics.com/20130930/role/idr_DisclosureCAPITALSTOCK CAPITAL STOCK false false R8.htm 000080 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.bioethics.com/20130930/role/idr_DisclosureRELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS false false R9.htm 000090 - Disclosure - GOING CONCERN Sheet http://www.bioethics.com/20130930/role/idr_DisclosureGOINGCONCERN GOING CONCERN false false R10.htm 000100 - Disclosure - LOSS PER SHARE Sheet http://www.bioethics.com/20130930/role/idr_DisclosureLOSSPERSHARE LOSS PER SHARE false false R11.htm 000110 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.bioethics.com/20130930/role/idr_DisclosureSUBSEQUENTEVENTS SUBSEQUENT EVENTS false false R12.htm 000120 - Disclosure - ACCOUNTING POLICIES (Policies) Sheet http://www.bioethics.com/20130930/role/idr_DisclosureACCOUNTINGPOLICIESPolicies ACCOUNTING POLICIES (Policies) false false R13.htm 000130 - Disclosure - Amounts Used In Computing Loss Per Share (Table) Sheet http://www.bioethics.com/20130930/role/idr_DisclosureAmountsUsedInComputingLossPerShareTable Amounts Used In Computing Loss Per Share (Table) false false R14.htm 000140 - Statement - COMPUTING LOSS PER SHARE (Details) Sheet http://www.bioethics.com/20130930/role/idr_COMPUTINGLOSSPERSHAREDetails COMPUTING LOSS PER SHARE (Details) false false R15.htm 000150 - Statement - Capital Stock Transactions (Details) Sheet http://www.bioethics.com/20130930/role/idr_CapitalStockTransactionsDetails Capital Stock Transactions (Details) false false R16.htm 000160 - Statement - CAPITAL STOCK CONTRIBUTION (Details) Sheet http://www.bioethics.com/20130930/role/idr_CAPITALSTOCKCONTRIBUTIONDetails CAPITAL STOCK CONTRIBUTION (Details) false false R17.htm 000170 - Statement - RELATED PARTY TRANSACTION (Details) Sheet http://www.bioethics.com/20130930/role/idr_RELATEDPARTYTRANSACTIONDetails RELATED PARTY TRANSACTION (Details) false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - UNAUDITED CONDENSED BALANCE SHEETS Process Flow-Through: 000030 - Statement - UNAUDITED CONDENSED BALANCE SHEETS PARENTHETICALS Process Flow-Through: 000040 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Process Flow-Through: 000050 - Statement - UNAUDITED CONDENSED STATEMENTS of CASH FLOWS Process Flow-Through: 000140 - Statement - COMPUTING LOSS PER SHARE (Details) Process Flow-Through: 000150 - Statement - Capital Stock Transactions (Details) Process Flow-Through: 000160 - Statement - CAPITAL STOCK CONTRIBUTION (Details) Process Flow-Through: 000170 - Statement - RELATED PARTY TRANSACTION (Details) both-20130930.xml both-20130930.xsd both-20130930_cal.xml both-20130930_def.xml both-20130930_lab.xml both-20130930_pre.xml true true XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
UNAUDITED CONDENSED BALANCE SHEETS PARENTHETICALS (USD $)
Sep. 30, 2013
Dec. 31, 2012
Parentheticals    
Common Stock, Par Value $ 0.001 $ 0.001
Common Stock, Shares Authorized 25,000,000 25,000,000
Common Stock, Shares Issued 11,000,000 11,000,000
Common Stock, Shares Outstanding 11,000,000 11,000,000
XML 23 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMPUTING LOSS PER SHARE (Details) (USD $)
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2012
Sep. 30, 2013
COMPUTING LOSS PER SHARES:        
Loss from continuing operations applicable to common stockholders (numerator) $ (5,758) $ (7,858) $ (19,522) $ (17,352)
Weighted average number of common shares outstanding used in loss per share calculation during the period (denominator) 11,000,000 11,000,000 11,000,000 11,000,000
XML 24 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
UNAUDITED CONDENSED STATEMENTS of CASH FLOWS (USD $)
9 Months Ended 278 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Operating Activities:      
Net loss $ (17,352) $ (19,522) $ (193,914)
Changes in assets and liabilities:      
Increase (decrease) in accounts payable 0 997 0
Increase (decrease) in accrued interest 3,376 2,502 10,667
Net Cash (Used) by Operating Activities (13,976) (16,023) (183,247)
Cash Flows from Investing Activities:      
Net Cash Provided by Investing Activities 0 0 0
Cash Flows from Financing Activities:      
Proceeds from common stock issuance 0 0 41,000
Capital contribution 0 0 62,776
Proceeds from notes payable 10,000 20,000 80,000
Net Cash Provided by Financing Activities 10,000 20,000 183,776
Net Increase (Decrease) in Cash (3,976) 3,977 529
Cash at Beginning of Period 4,505 6,989 0
Cash at End of Period 529 10,966 529
Cash paid during the period for:      
Interest 0 0 0
Income Taxes 0 0 0
Supplemental schedule of Non-cash Investing and Financing Activities $ 0 $ 0 $ 0
XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
UNAUDITED CONDENSED BALANCE SHEETS (USD $)
Sep. 30, 2013
Dec. 31, 2012
CURRENT ASSETS    
Cash $ 529 $ 4,505
Total Current Assets 529 4,505
Total Assets 529 4,505
CURRENT LIABILITIES    
Accounts payable 0 0
Accrued Interest Payable - Stockholder 10,667 7,291
Notes Payable - Stockholder 80,000 70,000
Total Current Liabilities 90,667 77,291
Total Liabilities 90,667 77,291
STOCKHOLDERS' EQUITY (DEFICIT):    
Common stock; $.001 par value, 25,000,000 shares authorized, 11,000,000 shares issued and outstanding 11,000 11,000
Capital in excess of par value 92,776 92,776
Deficit accumulated during the development stage (193,914) (176,562)
Total Stockholders' Equity (Deficit) (90,138) (72,786)
Total Liabilities and Stockholders' Equity (Deficit) $ 529 $ 4,505
XML 26 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Amounts Used In Computing Loss Per Share (Table)
9 Months Ended
Sep. 30, 2013
Amounts Used In Computing Loss Per Share  
Amounts Used In Computing Loss Per Share

The following data show the amounts used in computing loss per share:

 

 

For the Three

Months EndedSeptember 30,

For the Nine

Months EndedSeptember 30,

 

    2013

    2012

2013

2012

 

 

 

 

 

Loss from continuing operations

 

 

 

 

applicable to common

 

 

 

 

stockholders (numerator)

$      (5,758)

$      (7,858)

$      (17,352)

$      (19,522)

 

 

 

 

 

Weighted average number of

 

 

 

 

common shares outstanding

 

 

 

 

used in loss per share calculation

 

 

 

 

during the period (denominator)

11,000,000

11,000,000

11,000,000

11,000,000

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
CAPITAL STOCK CONTRIBUTION (Details) (USD $)
60 Months Ended
Dec. 31, 2009
CAPITAL STOCK CONTRIBUTION:  
Received shareholder contributions $ 62,776
XML 28 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2013
ACCOUNTING POLICIES  
Organization

Organization - Bioethics, Ltd. (“the Company”) was organized under the laws of the State of Nevada on July 26, 1990. The Company has not commenced planned principal operations and is considered a development stage company as defined in ASC Topic No. 915. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of, and at the complete discretion of, the Company’s officers and directors.  The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.

 

condensed financial statements

Condensed Financial Statements - The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2013 and 2012 and for the periods then ended have been made.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2012 audited financial statements.  The results of operations for the periods ended September 30, 2013 and 2012 are not necessarily indicative of the operating results for the full year.

 

XML 29 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CAPITAL STOCK
9 Months Ended
Sep. 30, 2013
CAPITAL STOCK:  
CAPITAL STOCK

NOTE 2 - CAPITAL STOCK

 

Common Stock - In July 1990, in connection with its organization, the Company issued 1,000,000 shares of its previously authorized but unissued common stock.  Total proceeds from the sale of stock amounted to $1,000 (or $.001 per share).

 

In May 1998, the Company issued 10,000,000 shares of its previously authorized but unissued common stock.  Total proceeds from the sale of stock amounted to $40,000 (or $.004 per share).  The issuance of common
XML 30 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 31 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capital Stock Transactions (Details) (USD $)
Sep. 30, 2013
May 01, 1998
Jul. 01, 1990
Capital Stock Transactions      
Company issued shares previously authorised but unissed common stock   10,000,000 1,000,000
Total proceeds from the sale of stock amounted   $ 40,000 $ 1,000
Per share value   $ 0.004 $ 0.001
Shareholders contributions $ 62,776    
XML 32 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Sep. 30, 2013
Nov. 12, 2013
Document and Entity Information    
Entity Registrant Name BIOETHICS LTD  
Document Type 10-Q  
Document Period End Date Sep. 30, 2013  
Amendment Flag false  
Entity Central Index Key 0000894560  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   11,000,000
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q3